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ISUMMARY
European Heads of State and Government have agreed that medical care and work in
related technological areas represents a priority area for European cooperation. This
includes, as oqe specific line of action the exoloitation of the advances in information
technoloqies. telecommunications and broadcastine to improve medical care and support
the underlying technological effors in medicine and biotechnology.
Health is next to food and shelter one of the basic human needs. Conscious of the high
priority of health care and of the growing possibilities, but also of the cost constraints,
the Community needs to optimize its efforts towards this common objective. Leading
experts have joined the Commission in identifying actions which are suited to exoloit the
technoloeical advances in Medical and Bio-informatics so as to bring the maximum care
to the patient while staying within reasonable limits of individual and collective
expenditure.
The Community initiative in Medical and Bio-informatics (MBI) is to be seen as part of
a concerted effort in related domains, both medical and technological, on which it builds
and of which it forms a specific action to re-inforce progress and draw systematically on
the benefits of collaboration on a European scale in the 
_f.orm of greater cost-
effectiveness and a faster propagation of the best practices. (l). The conception and
development of new health care technology and services calls for an optimal use of
human resources, facilities as well as financial means and the participation of all the
main sector actors. Broad consensus and participation is a key requirement for success
and progress in this domain where social and human considerations are of outstanding
importance.
Based on exploratory work in 1985/86 involving 150 leading experts (') 
" 
progr"mme of
cooperation in MBI has been developed of which this proposal represents the Pilot Phase.
The global objective is to serve the concertation of European efforts towards
sustained improvement in health care in the Community for the 1990's within
economically acceptable limits by exploiting the potential of Medical and Bio-
informatics.
AIM is designed in such a way that it will contribute to the strengthening of the internal
market and free competition for health care related equipment and services which
depend on compatibility and interoperation of information processing and
communication. It will do this by
- fostering work which will lead to the identification of common functional
specifications, minimum standardization and conventions for Medical
Bioinformatics for health care related telematics which is the pre-requisite for
an open cornpetition and the strengthening of the market for information and
telecommunication assisted health care services:
stimulating the standardization work in related areas and contributing to the
specific work required for MBI equipment and services;
In particular the Medical Research Programrne, ESPRIT, R.{,CE and the vork on gtandardization and
certi{ication
BTCEPS Planning Exercise and Exploratory Investigationr in f985/6
r)
2l
- fostering Community-wide open competition of ideas and approaches to
developing specific MBt-based health care concepts and services at the pre-
normative and pre-competitive level;
- initiating reflection on the adaptation of the regulatory framework facilitating
Community-wide collaboration in developing and using advanced medical and
bio-informatics to improve the quality and cost-performance of health care.
The proposal consists both of 'precompetitive systems R&D' and of pre-normative
.""ror"j concerning the establishment of synergy in developments in related applications
(personal computing, consumer electronics, telecommunications and broadcasting) which
*itt Ue beneficial for an open competition on a European market place.
AIM at the technological level situates itself at the'pre-competitive' and'pre-normative'
stage, while being quite specific as to the objectives to be achieved' The present
sitiaiion being on- oi .*tr.nr" fragmentation and, for advanced work, subcritical effort,
the suggested worksharing and cooperation can be expected to reduce duplication but not
so ex;nsively as to consirain competition. The allocation of contracts will be based on
an open combetition and in some cases it may be desirable to explore several competing
concepts as a means to a stated objective.
AIM will help to establish the basis for a European market for Health care services.
However, AIM designedly does not include development or production as such, but only
the common tools and facilities this will require.
In its contribution to standardization and certification AIM will help to stimulate
competition by early on defining principles and initiat development conventions.
Within these general objectives AIM is expected
- to make major contributions towards improving quality, flexibility and
accessibility of health care in the Community;
- to increase the effectiveness of patient care in order to bring about a reduction
in the cost of health care;
- to make a major contribution towards increasing that part of the . sector
resources which'directty benefits the patient and assists the medical profession
in their mission;
- to contribute to the establishment of minimum standards and common
functional specifications prerequisite for the emergence of a strong and
competitive 
-Europ""n 
industry providing medical informatics equipment and
services;
- to contribute to the development of agreed codes of good practice, protection
of privacy, anO reliability for medical informatics as a prerequisite of
appiopriatl regulation and protection of the patients privacy;
- to stimulate collaboration and concertation in the analysis of the requirements
and opportunities in MBI and its application;
(1)
3- to contribute to the common adaptation of the regutatory framework to
advances in the nature of health care.
AIM will pursue these objectives through the more effective deployment in the
Community of new MBl-techniques
- to support all branches of health care, including prevention, diagnosis,
treatment, the medical record and its analysis; and
- to support the advance of research in related scientific and technological areas
by using MBI to increase R&D-productivity.
AIM directly cotrcerns
- the national authorities administering health care,
- staff providing health care,
- 
patients receiving health care,
- the medical equipment industry,
- the communications industry',
- medical and biotechnology researchers,
and strongly concerns the interests of ::
- health insurance
- the pharmaceutical industry
- medical education and training institutions.
AIM is to be implemented in a phased approach starting with a Pilot Phase which is the
subject of this proposal. Subject to a successful implementation of the Pilot Phase a
Main Programme extending initially over 5 years may be proposed.
The nature of the work proposed includes
- analvtical work towards the identification of common requirements and their
functional characteristics;
- ore-normative work on MBI towards common functional specifications and the
development of minimum standardization proposals;
- ore-comoetitive work as required to establish the techno-economic feasibility
of common functional specifications and standardization proposals;
- verification of standards and their testing with respect to the functions and
operations they are to support in medical care and biotechnological research;
- contributine to the raoid exoloitation of the results by systematically
familiarizing the health care professionals with the potential of MBI
applications.
In order to carry out the Pilot Phase of the action described in this communication, it
has been estimated that 300 Man Years of work will be required. Industry is expected to
contribute at least 50% to this action. For non-profit making participants not receiving
any related support from other sources the requests for support of up to 1009$ may be
considered. Assuming that 2/3 of the projects can be supported at a level of 50% and
| /3 can only be carried out by higher funding levels, the amount of Community funding
is estimated at 20 MECU over a period of 18 months.
1. INTRODUCTION "THE CHALLENGE IN MEDICAL CARE"
After a mainly evolutionary advance in health care, recent decades have seen a
considerable acceleration driven by scientific and technological progress as well as a
strong and lasting commitment of large resources to this objective. Some of the new
means already available and the potential of the coming decades may well revolutionize
health care. This is of obvious social consequence but it is also of considerable political
and economic imporance. Europe can pride iself on a leading role in some areas of
health care and the related scientific domains. However, as the need increases for
concentration of efforts, skills, facilities and financial resources for R&D in related
domains such as biotechnology and medical informatics, so Europe is rapidly falling
behind. Cooperation between scientists, research centres and increasingly with industries
is becoming a necessity to engage and stay in this high-technology domain.
For a more cost-effective approach to the challenge in health care and related
technological R&D, flexible and effective frameworks for concertation and cooperation
are required which permit the sector actors to make their respective contributions within
a consistent perception of objectives, thereby avoiding redundancy where it is wasteful
and focussing resources on central objectives.
t.l Growins opoortunities in medical care and the imnticit role of informatics
The last decade has seen
- the introduction of powerful diagnostic tools based on technological progress in
the medical field as well as the systematic application of MBI, e.g. magnetic
resonance (MR), computer tomography (CT), nuclear medicine (NM),
ultrasound, digital subtraction angiography (DSA), etc.;
- the integration of these tools into department-wide systems;
- the introduction of more precise and less invasive therapy methods, such as
laser angioplasty, endoscopic surgery, extracorporeal shock wave lithotripsy
(ESWL), and precision radiotheraphy;
- the emergence of biotechnology, intimately linked with the progress in
bioinformatics, as a new driving force of techno-economic change, with the
bulk of expenditure in biotechnology effort being focused on health care in the
areas of therapeutics, diagnostics, selective delivery systems, and immunology,
bringing greater understanding, information intensity, screening possibilities,
grearer precision of diagnosis and therapy, rational drug design, genetic
intervention;
- the penetration to the bio-molecular level of analyses, diagnostics, treatment
and bio-engineering assisted by some of the most advanced products of
information-technol,ogy, eg gene-mapping, computer-assisted engineering of
substances, computer simulation of biOmolecular prOcesses, etc;
Figure l
-_t
oc
ca,
Oh
E.J(s
d\(q
oo
:FoE.J Cr 8is
au33\rD g cOE
aJ t,
Rtsb3[b 3€Ec-ohi\() E
D
d
oA
cot
.|Jcro
oE(J
EOLTL Ola
og>q-cL
co0l
H=(')
cro\
G
o
\CL\a\r$
o
:
.ri
a
.c t\{J OL) hrr \
of,L .!tPf rI; 3i* Q\f, !Yoo L ! t1.ooo(L{rc \Otr tl- t\ o
o5$oEoEoo.- (.- o Q-G O.-i;;s€:bEitiSf S,S{{.3
N
!t
r)
rlD\o
\t)
(D
+>
c/)
l'- ,ca
a)
e
r\)
<->
-+-:r
{5
--{
*-i
---5
q.-{
a
-
\J-'
<)
Cra)
o
;
o
eo ;5
4t q''a
cQ.$
.i Og
-(tF;T\ t(i.COB
f, a'-EIr-'- s E
-:soc: g trr|(()o
o({-Ca- Eoottr;(cEi Cl E'-6rs:(t\(J>
SsEC'- ar
::;[GE*P
Ea)\Ho
o.-t-qob\ a
F::IF.OOQ
oooo,FO(U(
* sbg
.dt85FQO.L)
{J
J)
c(
-L
c,
o
n
sI
\j
(!,
c
n
+)
tJ
L
Ell
u,
L
0
!
c,
-L
oo
:J'
dr-
-"L.n
lf,o
'Ji <*
t>,
L
.c(J+)
-r$
JJL
a-oco
CtF
'a&o
ir \i oc i/G;i d Il&.'i\iili
Yu8/-\,/
V
i
(J
^.,;:Ly$og-q tOGqc( tuQ'-
art !1
rf 'tr ! r!)
-'d c ( ct)
oooS'.3S
r. O.lf,s O€
F; S{3'xoE o!o qrqq-'^
.E ro o ot-
uJ c o\\s
'-cEE(
eo'^ O Q gr
-:t:tto
=f,ocoE
-\ro(o()a{=(f,rrilrlQ
I
I
I
I
I
I
__J
:>:
'.,t
!, la-
(E
L'b&i:c({o
-(
,*l x
a
C
fi
(J
=
co
6Table l:
SCOPE OF APPLICATIONS OF MBI IN
BIOMEDICAL R&I)
Medical Bio-Informatics is strongly
embedded in all sectors of health care and
the scientific/technological activities it is
based on. The following listing gives
examples where MBI is playing a
particularly strong role.
PREVENTION
Effortr rrc incrcesing in prcvcnting hcelth problcmr
from eriring or from rcaching e lcvcl rhcrc thcrrpy
bccomcr ncccllrltf. Exr,rnplcr rhcrc MBI ir importent
includc:
- rcrccning of tisruc nmplcr for canccrour ccllr
- cpidcmiologicd rcnccning of thc population
- rcarch end idcntificrtion of ncw dircarcr end hcalth
problcmr
- informetion rnd cducetion of thc populrtion (cg
uring thc mcdir in thc cerc of AIDS)
DIAGNOSTICS
Computcr aggistcd dianogtics
- Expcrt Syrtemr
- Data Bascg
Imarins
- Digitd radiology and digital angiography
- Computcr Tomography
- Nuclcar Medicinc
. ringle photon cmigtion computcr tomography
(sPEcT)
. poeitron cmiarion tomography (PET)
- Magnetic Resonance
- Echography
- computcr ercirtcd diagnorir.
Laboratorv cquioment
- Molccular ebrorption tpcctrophotomcter
- Liquid chromatography
- Electrophorerie
- Blood cclls counter
- Elcctronic microrcopcr
- Cytofluorimetcn
- Microrcopc image andylerr
- Doctor'r oflicc tertr
- Microbiology anelyrcrr
- Spccific user of MBI to achicve
. rcliability
. rpced
. non-invgivcncg
. mini*urilrtion rnd portability
. rutonomy
. intcropcretion
. rrmotc control ud monitoring.
TIIERAPY
Ilirh precirion rediothcrapv
- Brechythcnpy
- Prccirc dynmic bcam control
Fibroccoov
- Cluricrl fibrorcopcr
. plrrtic end rilica fibrcr
. bundlcr
- Vidco-cndorcopy
. GCD trensduccrr miniaturiration
- Infrlrd thcrmogrrphy
. lnfrarcd photodctcction
Ncw rurricel tcchnioucr
- Elcctrotomc
- Cryoeurgcry & coagulation by electromagnetic wave
- Thcrapcutic larcr
- Lithotripry & ultraronic lancct
- Opcrating microrcopy
- Lifc rupport lyltcm!
Scnrorg for in vivo dieEnogticr
MEDICAL COMMUMCATIONS
In Prcvcntion/Earlv Dctcction/Self Care
- Uac of tclccommunications networkc for
cpidemiology purpo.c! and medical counaelling
- Computcr arcirtcd system! providing health
information, . hcalth education, training in
clcmcntarlr health care.
In Primarv Care
- Profcrrionel medical informetion ayrtem
- Mrnagcmcnt of rcfcrtal
- Mcdicel rccord data collection and analysis
- adminirtration of hcalth chcck-upr
In Sccondanr Carc
- Hocpital communicrtionc
- Rcrourcc rchcduling
- Prticnt rccord data beccg
- Clinicd rcrcarch
- Dete proccuing for rncillary rcryicct
- Intcgrrtcd horpitd information ryrtcmr
a
- Medicd rccordr mlnrgcmcnt
- Dccirion.upport for mcdical rctourtc mtntgcmcnt
- Hcalth rtrtirticr
- Epidcmiology
- Surcillancc functionr
- Mcdicd informrtion mrnagcmcnt
. leecr cerdr and dirkr
. largc drte berc murgcmcnt tcchniquce
. rdveoccd dccirion .upport
. edvanccd prcrentation ridr
BIOMEDICAI, NESEARCH
- Supcrcomputing in bio-molccular rcrcarch
- X-rey cryrtellogrephy aud anrlyrir of rtructurcr in
rolution
- Dynamic modclling of biological ryrtcme
- Gcnc mapping end rcqucncing
- Protcin cnginccring
- Artilicial intelligencc u r rcrear.ch rupport tool.
MEDICAL TRAINING
- Computcr-barcd aimulation in diagnorie
- Expcrt ryetcmr er diagnostic chcck and in tutoring
- Computcr arsirtcd rpccid rkill treining
etc.
- an unprecedented growth in medical and related scientific knowledge, e.g.
. the number of researchers in life sciences represents about 25% of the total
number of scientiss;
. the number of distinct diseases recorded in medical literature has increased
more than tenfold since 1900;
. the number of pharmaceutical products, which presently exceeds l0 000,
increases by about 250 each year;
. in recent years biotechnology has resulted in dramatic progress in the quality
and production economics of pharmaceutical products;
Throughout MBI has been instrumental and an essential ingredient of progress.
Figure I and Table I illustrate the role of medical and bioinformatics in Health Care.
1.2 Medical care is a maior socio-economic sector with ereat ootential for the future
- with roughly 8% of the GDP of Member States going into medical care, this
sector is comparable to spending on Defence and bigger than
Telecommunications:
- within the European Community there are roughly 800 thousand doctors and
15 thousand hospitals with more than 3 million hospital beds for a population
of about 320 million. This makes it the biggest service sector;
- with a growth rate of 8% per annum, health care services are one of the most
rapidly expanding markets in Europe. Within this the growth-rate of MBI is
about 15% per annum and is expected to increase its importance over the next
decade until it represents 5% of the equipment and service expenditure. Due to
the continued rise in expectations of improving the quality of life medical care
can be expected to remain a crucial sector in future societal developments;
- non-pharmaceutical medical products represent today a market of about ECU
25 billion market worldwide, growing at a compound rate of l0% per annum.
Europe's part of this market is only 20%, despite the size of is population
and the growing demand.
1.3 Characteristics of future develooments
Future trends will be shaped by growing demand for health services (world wide and in
developed countries reinforced by demographic factors) and rapid advances in science
and technology constrained primarily by the cost of providing health care.
Technology will be instrumental in
- offering more cost-effective means of diagnosis and therapy
- contributing to the further improvement of existing techniques of health care
- offering better adaptation to the needs of patiens, doctors and health care
services,
but will at the same time, in order to improve the delivery, organization and
management of health care
permit improvements in providing health care in hospitals as well as in
ambulant services (eg home health care)
- offer new and enhanced possibilities in supporting training and specialization
of medical staff, and
9- facilitate the administration of medical data and accounting.
This can be expected to occur as a rapid evolution. However, some of the changes are
likely to affect strongly the organizations involved in health care and the division of
labour between different branches of health care. trmplicit in this evolution are major
structural changes involving all parts of health services including the supporting services
and extending to the regulatory and legal environment as well as training and
qualification of health care staff.
The exact evolutionary paths are difficult to assess at this stage, but some of the main
features can be identified and attention be focused on them. The following section
outlines a scenario of the kind of heatth service which might emerge in the late 1990's.
1.4 Medical care bv the vear 2000
The technological developmens of the coming decades will extend the possibilities of
health care and at the same time remove traditional constraints to providing care. Health
care will have been much more adapted to the needs of the patients, ie offered when,
where and in the way the patient wishes, rather than according to the location and
organization of health care infrastructures and services.
Some examBles can serve as illustration of the kind of changes one may see:
t) "Telemedlcine": Certain *realth care services, in particular of a diagnostic
kind, could be offered by the use of advanced telecommunication services,
combined with new techniques of diagnostic packs, which permit the patient to
provide the doctor with the essential information. The benefit would be to
reduce the necessity of moviing patients and improving the access to the doctor;
2) "Ooen Hosnital Care": With the advance in medical equipment technology,
their interworking with telemetry and remote control, it becomes possible to
provide hospital-type care outside the constraints of hospital complexes;
3) llntesraled nosprtalesrea An Integrated Hospital approach would bring the
therapy and diagnostics to the patient instead of moving the patient to the
facitities as is today largely the practice. This becomes possible only as a result
of a systematic development of health care technology and their interoperation;
4) "Customized nharmaceuticals": As part of an integrated approach to health care
and supporting services it witl become possible to interpret the diagnostic data
and treatment strategy in terms of designing patient-specific prescriptions. This
will include drugs themselves, the mode of administration and the rate of
aclministration. The drugs can be expected to include conventional
pharmaceutics as well bioerngineered products. The advantages of tailoring
drugs and their delivery to the specific needs of the patient are considerable.
The side effects could be re:duced and thereby the speed of recovery could be
expected to improve and the need for further treatment minimized.
Many othor features and changes in the way health care is offered can be expected to
emerge. When and how they will be seen depends on several factors, BUT one of them
is comrnon to ail scenarios, the dependence on f'unctional integration and interoperation
of equiprnent and services as offered by MBI.
t0
2. OPPORTUNITIES AND ISSUES IN MEDICAL. AND BIO.INFORMATICS
2.1 Socio-oolitical dimension
Health care and the use of technology to support it must, more than other domains take
into account the social dimension. The use of technology, the organization of health care,
the way it is offered need to be governed by and centred on human relations. This
implies that the consideration of all use of technology in medical care directly relating to
the patient or the patient's relationship with medical staff needs to be conceived and
developed in accordance with the medical and psychological needs of patients and
medical staff. Human Factor Engineering needs therefore, to play a central role in
developing MBI where it relates to the pati€nt and the patient relationship with medical
staff.
The proper understanding of the human element and its relationship to technology is a
crucial etement for acceptance and therefore utility. Furthermore the economic success
of the related equipment, products and services is largely affected by the success in
addressing this issue.
In the MBI domains not relating directly to the patient-doctor relationship but to the
utilisation of MBI within the professional medical services, good adaptation to meet
user needs is also very important and needs to be addressed, but is not of the same
paramount importance as in the patient-doctor context, where it is crucial.
The reason for stressing this point in the context of pre-competitive and pre-normative
work is that more and more of the features of the ultimate application are conceived at
the early research stages, ie the social dimension needs to be included as a research
objective and design criterion already at this stage.
2.2 Conversence of health care and information services
Health care is the result of the systematic use and integration of many approaches and
techniques. But all of them depend to a very large degree on communications between
the patient and medical staff on the one hand and between medical specialists and
associated services on the other hand. It is, therefore, to be expected that health care
will increasingly exploit the enhanced possibilities of telecommunications. Now already
medical advice is being offered via the telephone. With the emergence of broad band
services one can expect that this kind of medical service will expand progressively.
Videoconferences between specialiss in different parts of the world on a particularly
difficult case, may become standard practice in the 1990's, to mention just one example
relating to the work of doctors. Biochemists supporting health care already rely on
protein data bases developed and maintained by experts world-wide. This kind of
development can be expected to expand rapidly offering progressively more powerful
research tools.
In technical terms this means that health care is a leading-edge user of information
services ranging from broad-band services to very sophisticated data base management
systems making use of the iatest in artificial intelligence. While the basic techniques will
be in common between biomedical information services and many others, there are
additional specific requirements which need to be taken into account, eg relating to the
development of common functional specifications and minimum standards so that the
uninhibited use of these services becomes possible.
ll
2.3 Convereence of Biotechnoloev and Information technoloev (Masterine the
comolexitv)
Biological systems are the most complex known and investigated by man. Progress in
understanding has, therefore, at all times to be closely related with the ability to gather
information, analyze and interpret it. The scientific basis of future health care is to be
found largly in the understanding of the molecular basis of biological processes. This
may include the analysis and interpretation of millions of atoms making up the
biomolecular functions. One refers, therefore, in this context to'Megacomplexity' which
needs to be dealt with. It is for this reason that progress in biotechnology is intrinsically
linked with progress in information technology. Invenely, the biological processes are
increasingly serving as model for advanced work in information technology. For this
reason it is expected that in the long term information and bio-technology will converge
to a significant extent
2.4 Soeed of evolution
The scientific basis of medical care is evolving so rapidly that some refer to mankind
facing a revolution. The reason for this lies in the fact that biotechnology has reached a
level of maturity where its application has come within reach. The application potential
and the associated economic potential have resulted in a major change in approach and
scale of efforts. Increasingly large resources in terms of money, equipment and human
resources are focused on specific objectives. Those countries who wish to maintain
strength in this domain will need to reflect not only on the financial resources but in
particular on the organization and orientation of their efforts. Providing a highly
dispersed scientific and technological community with a common framework for
collaboration is one of the necessities implicit in this trend to more concentration and
requirement for scale.
2.5 Masterine economics and shortaees in technoloeical resources
Health care and all associated disciplines are major sectors of activity to which very
considerable financial and human resources are dedicated as well as extensive facilities.
Already this domain is highly capital intensive in the research stage, development, trial
and application. This trend can be expected to continue and with the emerging
biotechnology the requirements for scale of R&D efforts needed to participate in
advanced work may reach the dimensions known to govern other high-technology fields
such as aerospace and information technology. Cooperation is then not only an advantage
but becomes a necessity in term of financial as well as expert human resources. The
interdisciplinary nature of health care re-enforces the need to cooperate between
different domains.
Success in meeting this challenge in economics (financial as well as in human resources)
depends on setting up effective frameworks supporting the various sector actors in
making their respective contribution- The action under consideration is to assist the
sector actors in domains where the European dimension offers the most advantageous
framework of action.
t2
2.6 Conclusions
- Health Care is of central socio-political as well as economic importance for the
Community. The demand for further improvements are increasingly being met
by advances in science and technology.
- All European countries (and most others in the world) face serious problems in
the growth of their health delivery systems. For some the percentage of GNP
spent on health care has reached at least 6 %, depending on what is seen ar
part of the health budgeq it easily can be also seen as already surpassing the l0
% limit in some EC-member nations. Though most experts consider this level
of expenditure the maximum economically acceptable one, still most countries
are conscious of deficiencies in their health system which they try to overcome
by setting up new institutions and programmes.
- in spite of the differenccs in the socio-economic structure of the health care
systems in the EC-member nations, these developmental areas provide a high
degree of commonalty, ie a chance, if not the need, for joint efforts at
Community level specifically in the area of advanced informatics.
- The field of medical informatics itself provides several excellent test beds and
leading edge development areas for informatics in general.
- Medical information technology is a world market, as can be seen by the
strong and still growing role that non-EC-based companies play in Europe and
EC-based companies play outside Europe in areas like Hospital Information
Systems, Medical Laboratory technique, and dedicated Systems in Image and
Signal Processing.
- The future role of medical informatics will include:
. the support of well understood routine tasks in broad application areas,
efficient, cheap and robust enough to serve throughout the Member countries;
. the provision of knowledge and expertise in situations and localities where
these will not be routinely present, thus enhancing the quality of local problem
handling;
. the provision of local and regional communication facilities to provide
pertinent patient data wherever and whenever needed, while observing privacy
and security, thus reducing unnecessary replications of check-ups and delay of
action;
. the provision of aggregated data for more efficient health care resources
planning. These and other effecg which can be expected from a strategic
implementation of medical informatics can be generalized to play a role in
quality assurance, cost containment and equality of social service as well.
- The initiative is timely since:
. several Member States of the EC are now at the point of starting or developing
pilot projects and R&D programs to promote their information technology in
medicine on the national tevel, e.g. in areas such as informatics for primary
health care, regional health information services, hospital information services;
l3
with the advent of personal computing and powerful mini computers,
computing now becomes affordable on a broad scale to hospitals, general
practitioners and other health care providers;
advances in telecommunications and radio open up new possibilities for health
care, eg mobile integrated services.
The functional integration of health care equipment and services made possible
by the advances in MBI permits the realization of major advances in the
quality and economics of health care (economies of integration and economies
of flexibility).
The realization of advances building on the new possibilities offered by MBI
to improve quality and cost-performance depends on the collaboration of
several sectors (Medical Profession, Molecular Biotechnology, Laboratory
Instrumentation, Researchr Equipment, Telecommunications, Information
Technology as well as of the standardization bodies working on the related
domains).
Progress in MBI opens up new possibilities with the potential for making
health care more flexible arnd adapting it better to individual patient and needs
of medical staff.
Progress depends on the cooperation of independent actors making their
respective contribution in a coherent framework of action.
Shortage of human resources is in addition to lack of appropriate facilities and
finance the most important argument in favour of cooperation on a European
scale.
The exploratory work which has preceded this proposal has confirmed the
readiness of the sector actors to work together in this domain and identified
areas of opportunities for cooperation.
USA and Japan are investirrg large amounts of money in advanced informatics
in medicine (e.9. in expert systems, communication, image processing) whereas
at the same time dedicated US software companies are getting a growing share
of the existing medical computing market in Europe.
The existing R&D resources in Europe in certain areas like hospital
information systems, image processing, expert systems and others are
sufficiently strong to be ab,le to capture relevant market shares in Europe and
worldwide, provided that sufficient scale is achieved by joint efforts and
harmonization.
- AIM can build on the cooperative efforts, in particular, ESPRIT and RACE as
well as other advanced work realized in other frameworks and thereby
contribute to the exploitation of generic work done in these programmes.
AIM will combine tangible progress in the mid-term with work requiring longer term
efforts towards more ambitious objectives-
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3. OUTLINE OF AN ACTION PLAN
The central function of AIM is to improve the use of limited resources for thc advance
of health care and its constituent sectors. This includes human resources, facilities, and
finance but also the time element, so as to achieve accelerated progress in quality as well
as cost-performance.
This implies the purposeful cooperation of the sector actors within a consistent
framework of action. To this end, in order to make cooperation in such a complex
domain manageable and effective, the action should be structured by reference to the
main contribution each group of actors can make. The following Action Lines represent
an approximate structure of the envisaged efforts. During the Pilot Phase these will be
explored further and precise objectives as well as th€ optimal approach defined.
3.1 Action Line I
Improvement of the effectiveness of public end private actions
by means of
the development of a comrnon conceptuel fnmework for cooperation et the planning
and management level ln Europe.
This would be undertaken by the construction of a reference model (Annex, page 4\.
This model would embody the consensus of the main actors as to the common patterns
which underlie the activities of the sector, including the economic aspects. The model
would be composed of several sub-models, each representing one of the environments
which can be recognised within the sector.
In health care very considerable private and public efforts are being undertaken in
Europe. Their impact could be considerably strengthened by an enhanced concertation in
the stage of the definition of objectives, the derivation of requirements, the participation
in the evaluation as well as in the translation into applications
This Action Line would enable regular reports to be rendered, identifying objectives,
achievements, recommendations, approaches to economic evaluation, requirements and
indicating the orientation for future effors in the domain of MBI. These reports would
provide an integral view of the European situation and prospects in the world context.
3.2 Action Line II
Strengthening Europe's position in MBI and health care
by means of
cooperation in pre-normative and precompetitive technology exploration concentrating
selectively on re-inforcing and complementing the technology base of MBI and its
services.
This is to provide the reinforcement and minimum organizational framework necessary
for multidisciplinary cooperation drawing on Europe's assets in this domain.
This part of the action will need to involve medical practioners, researchers, the related
equipment and services industries as well as the related standardization bodies.
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Scooe
The ground to be covered under this Action Line would be the following headings of
the Workplan
- Medical Informatics Environment
- Data Structures and Medical Records
- Communication and Functional Integration
- Biomedical Expert Support Systems
- Biomedical Instrumentation and Research Tools
Information technology and telecommunications brings flexibility and helps to overcome
distance and access constrain8 to information. For this to benefit heatth care,
application-specific functional specifications and minimum standardization need to be
agreed upon by the health care sector. This is a pre-requisite for the improvement in
speed and accuracy of all information related processes in health care. Furthermore, it is
a prerequisite for the sharing of medical resources and equipment.
Therefore, one of the horizontal aspects of these activities to be explored early in the
action would be towards reinforcing the efforts in standardisation of medical
classifications as related to MBI, including diagnosis and data structures relating to
records, taking full account of data protection requirements.
Full advantage can be taken of the advances realized in information technology and
telecommunications generally only if a complementary effort is undertaken addressing
the aspects which are health care specific or specific to the needs of the related
biomedical and biotechnological research.
Therefore, other more technology-intensive collaborative, research activities would relate
to specialist fields such as expert systems for use in knowledge-base construction and
access as well as in more 'intelligent' human-machine interfaces, and to the exploitation
of MBI in medical laboratories and in research. This work would lead the way, via the
development of common functional specifications and minimum requirements of
standardisation referred to above, towards the exploration and development of advanced
MBI techniques by means of cooperation in pre-normative and pre-competitive R&D in
specific domains of MBI particularly relevant to progress in health care or related
research domains and suited for a transnational approach.
3.3 Action Line III
The creetion of an environment favourable to rapid progress in the introduction and
appropriate application of MBI in health care
by means of
the development of specific proposals addressing the policy, regulatory, legal,
organizational framework of MBI applications including the training and manpo\fler
related factors.
Scope
The work relating to this Action Line is identified in the lVorkplan under the heading:
- Non-technological factors.
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4. PHASING OF THE IMPLEMENTATION
Progress in this domain requires the purposeful cooperation of several actors within their
respective responsibilities. The challenge is as much in the motivation of the
collaboration as it is in the subject itsetf. However, motivation and a cooperative attitude
cannot be planned or decided but must grow and prove itself. A phased approach is
therefore suggested, permitting the progressive reinforcement of the effort as thedefinition of the objectives improves, the cooperation proves its value and the
commitment of the acto6 increases the credibility of the approach.
4.1 Pilot Phase
Following the completion of the exploratory work which has led to the formulation of
the proposd the full-scale implementation is to be preceded by a Pilot Phase. The pilot
Phase will serve to explore the scope and options to be included in the Main Phase, as
well as to develop and test the framework of cooperation. The work during the Pilot
Phase is to be exploratory in nature and self-contained, though representing the basis for
later work under the Main Phase.
The initial Workplan for the AIM Pilot Phase is annexed to this document. It will be
subject to revision by the Management Committee to be set up under the Decision
adopting the action.
4.2 Main Phase
The Main Phase will be proposed based on the success of the launching and
implementation of the Pilot Phase. Its objective will be to carry out the pre-normative
and where necessary pre-competitive R&D required to achieve measurable progress with
respect to the objectives identified for this programme and will be complemented by the
specific technical objectives in the Workplan which is to accompany the proposal for the
Main Phase.
5. ORGANIZATION AND MANAGEMENT OF THE COOPERATION
Cooperation in MBI, even at the level of exploratory work and advanced work, is very
demanding in terms of management and organization. There are several important factors
which already need to be taken into account in the Pilot Phase
- there should be for each component of the work a clearly defined objective in
terms of functional characteristics and cost-performance together with the
fixing of milestones marking progress towards the objective. The verification
of progress by this means is the ultimate measure of the technology
investment and the standard by which the results can be evaluated. It is not the
technical feasibility as such which matters but the techno-economic feasibility
and the benefit for health care;
- the health care system and its merger with research, information services
including mobile communications creates a high degree of complexity and
interdependence of future investments and applications;
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- there are numerous actors with their own respective responsibilities who need
to work together in a purposeful manner (the medical profession, service
providers, tiospitat and medical service operators, industry and on regulatory
isues also the respective adrninistrative and political authorities).
This makes organization and management of cooperation in this domain a challenge in
itself. Developing a sound apptoach to these questions will be decisive for reaching the
objectiues and m-ioimizing tne overheads inevitably associated with cooperation.
5.1 Evaluation
The evaluation is an ongoing process designed into the workplan including verifiable
objectives and assured iri ttre executi<ln by progress monitoring and milestone reviews'Tli evaluation of the project proposals ana of the results will be carried out with the
assistance of independlnt- explru. The overall evaluation of the Pilot Phase will be
carried out by the Management Committee itself.
An estimated overall investment of the order of 100 billion ECU in R&D for health care
will be made in developed countries over the next ten years. The work envisaged for
AIM serves to minimize risks and uncertainties as well as the optimal use of limited
human resources and finance. AIM relates to the initial R&D stage of very much larger
efforts required later on for product development. AIM is focused towards infrastructure
technologils where these are specific to health care and supporting scientific se-rvices and
relate tJ predominantly common requirements requiring large scale cooperation or the
establishment of a critical size of efiort by cooperation. lVhere international or national
projects are engaged with related objectives close coordination and collaboration between
the efforts is proposed and will be essential.
Eurooean countries
During the AIM Pilot Phase it is proposed to work closely together with existing bodies
and administrations working in ttris domain. This should where possible extend to
include public or private organizations established in non-Community European
countries.
The Community has a strategic as well as an operational and economic interest to come
to a European iolution for health care questions which also includes non-Member States'
Therefore, the Commission, intends to allow for the interest expressed by industry,
hospital operators, health caie service providers, and health administrations in the COST
countries by extending the criteria for participation in AIM.
It is suggested that private or public organizations established in cosT countries be
permitteld- to submit iroposals 
"nd to be signatories 
to AIM projects where a Framework
Agreement on R&D booperation has been concluded with the corresponding country.
The select organizations would, however, have to cover their own costs (plus, as
appropriate, a participation in the operational expenses)-
ProjecS with participants from theser countries would have to comply with the same
selettion criteria, contract conditions and management procedures.
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5.4 Secondment Scheme
In order to mobilize the human resources and make optimal use of research facilities it
would be of great advantage if experts from one organization could be associated with a
AIM project carried out by another organization where this is wished by both parties.
This mechanism would aid the organizations responsible for the respective AIM project
by providing additional skilled manpower and it would assist the seconding organization
in participating in the form of one of its experts in leading-edge work.
5.5 Particioation of SMEs. Research Orcanizations and Universities
The importance of SMES, Research Organizations and Universities as e strong inventive
and innovative element is well recognized and therefore their appropriate participation
will trc an important consideration in the implementation of AIM.
High technology SME s, Research Organizations and Universities will in general stand to
gain from AIM in that it creates a framework in which the specific strength of SME's
can express themselves and create market opportunities by fostering a symbiotic
relationship with large companies and service providers.
50% or more of the employees in the Community telecommunications industry are in
firms with 20-99 employees. This is an index for the variety of activities comprised
within this industry, the different effecg of scale between activities, and the extend of
sub-contracting. There is little doubt that this high degree of involvement of SME's,
Research Organizations and Universities will also characterize the future work in MBI
and AIM.
5.6 Overview of actions in MBI
In order to situate the objectives of AIM in the context of existing national and
international actions this section contains a strongly condensed overview of some of the
major activities which have been taken into account in the definition and orientation of
the proposal for the AIM Pilot Phase.
Belgium
Good level of R&D in medical informatics. Some research teams are outstanding in the
following fields : medical terminology, medical record administration, integrated hospital
systems, intensive care monitoring, data banks in cardiology, etc.
No national programme in bio-informatics, but some funding has been allocated to this
area through various channels (public bodies, BAP framework, etc.).
Denmark
Denmark cooperates with Finland, Norway and Sweden in two major medical
informatics R&D programmes : CART (Computer-Aided Radiotherapy) and KUSIN-
MED (Knowledge-Based Systems in Medicine).
(2)
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Publh funding for basic rcscarch in the general area of biotechnology comes from
general purpose appropriations channellcd through the Research Council in Science,
Medicine, Agriculture and Technology. There are presently two specialized programmes
relevant in the context of bio-informatics : the Biomolecular Technology Programme(Dkr 33 million ovcr 5 years starting l9E4), and a 5 year programme of basic rescarch
underlying industrially related developments in biotechnology (start 1985 with a total
budget of Dkr 60 million). The Danish government is considering e major effort in
biotechnology.
France
Medical informatics has receivcd in the past significant support from government, public
institutions (Agence de I'Informatique, Centre Mondial Informatique et Resources
Humaines) and national institutions (INSERM, CNRS). In addition, a number of
scientific associations are engaged in developing medical informatics, in particular
MEDIA, which groups 5 pilot tcams selected by the Ministry of Health. In 1965, Agencede I'Informatique helped establish a new association called Ophis, intended for
participating in the organization of the medical informatics market.
In biotechnology and bio-informatics, public funding of research operates at two levels.
First, there are a number of research bodies, including CNRS, Institut Pasteur, INRA
and INSERM, cach with its own funding, laboratories, staff, ctc. Secondly, France has a
specific programme, the 'Programme Mobilisateur Essor des Biotechnologies', originally
set up in 1982 and administercd by the Ministry of Industry. This programme has a
subprogramme in bio-informatics whose objective is to encourage and support the
utilization of computational tools in the development of biotechnological research and
industry.
cGR, a subsidiary of Thomson, is internationally active in the MBI sector.
Germany
In biotechnotogy, a major effort was launched in 1984, in the form of a programme
administcred by the Bundesministerium ftr Forschung und Technologie (BMFT)-. This
programme, which has a total budget of DM ll40 million, should be seen in the context
of local initiatives in the individual Linder. Although the programme does not
specifically identify bio-informatics as a research priority, tesearch in this area is
supported under this scheme. Between the Llnder the percentage of computerisation in
hospitals varies from about 80-t00%. The in-hospital usage of computers consists mainly
of mini-computers with the exception of large hospitat sites (eg in Monchen, Hannover,
G0ttingen, Aachen and Kiel) which have hospital computer centres. The main usage isin administration and financiat applications based on the use of software harmonised
with the support of governement.
Hessen has recently given a contract for a demonstration project for a state-wide
Hospital Information System.
In biomedical instrumentation, the FRG is the principal European manufacturer. Siemens
is the world leader in Imaging and, on its domestic market, stands well ahead of C.H.F.Mtller (a subsidiary of Philips), Hetlige (a subsidiary of PPG Industries) and CGR Koch
& Sterzel (a subsidiary of Thomson).
Many developments in medical informatics, especially expert systems.
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Greece
Funding of rcsearch in biotechnology aad bio-informatics is the rcsponsibility of the
Ministrics of Industry, Agriculture, and Health and lVclfare. There is work on basic
research in biology at univenities and research centres. Thcre is at present no national
research progrrmme rclating spccifically to bio-informatics.
Two companies, Vioryl and Bio-Hellas, are known for their work in biotechnology.
Ireland
Basic and applicd rcsearch in Ireland is supported by the National Board for Sciencc and
Technology (NBST), the Industrial Development Authority, the lrish Medical Research
Council, a number of private foundations, and directly by the government Departmcnts.
The NBST, which has the responsibility for advising government on Seneral matters of
science policy, has identified biotechnology as one of three areas in which research is to
be funded undcr a Strategic Research Programme. Bio-informatics has been identified
by the NBST as an important element in biotechnology and advanced molecular biology.
Italy
A National Research Programme, to be completed in 19E9, has been launched in the
biomedical field. For its execution a service company called Tecnobiomedica S.p.A. was
founded in December l9E0 to identify, set up and develop applied research projects in
the biomedical field. At present it is managing 16 research projects for an approximate
total amount of ITL E5 billion. In this framework 16 manufacturers are working together
with more than 20 research centres (Universities, Hospitals, Units of the National
Research Council).
Spccificatty relating to the field of Medical Informatics, there are several major activities
working on the use of artificial intelligence in medicine : Roma, Pisa, Pavia, Torino,
Milano, Padova, Genova, etc. However, the level of government support (National
Council of Research, Department of Public Education) for this work is comparatively
low.
The Nctherlands
Medical informatics is developed at Universities (Free University of Amsterdam,
University of Leiden, State University of Maastricht, State University of Groningen...)
and by industry (Philips and local subsidiaries of US companies such as Unisys,
Datapoint, SMS, Honeywell, Hewlett-Packard...).
Philips, which has in l9E? formed a joint venture with GEC, has a strong position on
the world market in specific sectors, eg imaging.
Portugal
Research is funded by the Research Council of the Ministry of Planning, which has
declared biotechnology and bio-informatics priority areas.
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Spain
Some projects are currently being developed in application of the National Informatics
and Electronic Plan.
Spain participates jointly with Denmark and Francc in a Eureka development programme
for non-invasive medical measuring methods ('Galeao/2000).
United Kingdom
There have been two major initiatives in advanced computing: the Alvey Initiative - the
British 5th Generation programme - and the three-phase programme initiated by the
Forty Report on Future Facilities for Advanced Research Computing. lVithin the Alvey
programme there were some projects directly related to medical informatics.
The IT 86 Report, which addresses the follow-up to be given to the Alvey Programme,
recommends a three-pronged programme: applications (ECU 700 million), research (ECU
770 million) and end-user education. Health has been considered as one of eight priority
application projects, with emphasis put on clinical data and process models.
Several UK centres are involved in advanced software developments for protein and
nucleic acid studies. The Cambridge Structure Databank (CSD) is one of Europe's most
important data bases for biological research.
The UK has strong activities in medical expert systems in research institutions (ICRF,
Imperial College, Manchester Univenity, Sheffield U., St-Thomas' Hospital, Sussex U.,
...) and industry (ICL, Logica, Oxford University Press, Hewlett-Packard...).
Funding for research in biotechnology and bio-informatics is provided by the
Department of Education and Science (DES) and the Department of Trade and Industry.
DES funding is mostly done via Research Councils: the Agricultural and Food Research
Council (AFRC), the Medical Research Council (MRC), the Natural Environment
Research Council (NERC), and the Science and Engineering Research Council (SERC).
British biomedical industry is relatively strong with a number of companies which are
competitive on strategic segments (imaging, monitoring, superconductive magnets for
MRI...). General Electric Company (GEC) is a major company in the imaging through its
subsidiary Picker International.
United States
The US was among the first countries seriously to address the application of computers
to the health care area, starting in the early 1960s. Most recently in 1983, the
implementation of Medicare's Prospective Payment System (PPS) for hospital inpatient
services has had a major effect on health care administration, resulting in a significant
boost for the computer industry as hospitals found their old systems unable to cope with
the new scheme. Presently 90% of all hospitals with more than 100 beds have some
degree of automation in the patient admission/handling areas.
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Federal funding is directed mainly to universities and colleges, and federally funded
R&D centres, through agencies such as the National Science Foundation (NSF) which is
the primary agency responsible for funding basic research at universities. The NSFs
budget will be ECU 3.2 billion by 1992, three times that in 1980. The Department of
Energy (DOE) plans to spend ECU 20 million to ECU 40 million a year on the'Genome
Initiative'for the next four to seven years after 1988. The objective of this project is to
map and sequence the entire human genome, thus accomplishing the tremendous task of
reading the exact sequence of the more than 3.5 billion chemical units.
Biomedical research instrumentation is mainly supported by the NIH (National Institute
of Health). In the fiscal year 1985 the Division of Research Resources (DRR) of the
NIH awarded 1103 research grans. The appropriations for the DDR amounted to 300
Million ECU.
The research division of the National Library of Medicine (MIH) was created to address
specifically the application of information technology and telecommunications to
problems in health care and to improve the system for collecting, processing and
disseminating biomedical information. In 1987 is activities included electronic image
processing, electronic document storage and retrieval, video imaging systems, knowledge
based information systems to name just some of the more ambitious projects.
Federal funding has also begun to flow into the private sector. Two kinds of federal
support concern MBI : SBIR (small business innovation research programme) and SBICs
(small business investment companies). Small high technology companies also receive
state and local support through various mechanisms (Corporations for Innovative
Development, State Pension Funds, venture capital) aimed at spurring innovation and
growth. As concerns local support, there are some very interesting examples, such as the
NBS-University of Maryland partnership on biotechnology (GARB), or the Chicago
Technology Park which, tog,ether with nearby University of lllinois and medical centres,
is reportedly the largest medical training centre in the world. US suppliers have become
world leaders in the provision of health care-related software products. Major suppliers
include IBM, Shared Medical Systems (SMS), McDonnell Douglas, DEC, Unysis,
Technicon Data Systems, which represent just a few of the 160 leading suppliers active
today in this market.
This results in a very strong position in the world medical equipment market and an
outstanding position in medical and bio-informatics.
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Japan
Public funding of research in MBI lies under the auspices of the Agency of IndustrialSciencc and Technology (AIST), the Ministry of International TLde- and Industry(Mm)' thc Ministry of Education, Science and Cutture, and the Ministry of Health.Exchange between public research and private research are very dense. On the basis ofthc fundamental technology about system control and filing information obtainedthrough past trial tests, and on the basis of adopting the newesi picture procesing and
stglaqe technologies, NfT has developcd a new interactive vidio information si"t".
called Vidco Response System (vRS). An cxperimentat servicc for 'Medical vRS. was
startcd on April 23, 19E6. In 1976 the Technology Research Association of Medical and
welfare Apparatus was established to meet the niic for products which are difficult andfinancially risky to develop and have low setling price. ln l9?4, the Ministry of Health
and MITI sct up the Medical Information System Development Centre (MEDIS DC). A
significant featurc of the growth of hospital information iystems has boen the increased
market share held by the native companies from 2096 in 1960 to t0r5 today, mainly
through the strategically directed production of small and medium-sized computers.Key players in medical informatics include Fujitsu, NEC, IBM Japan, Hitachi, and DEC
Ja-91n. Biotechnology-related market may reach yen 6 trillion uyitre-year 2000 (yen 25
million in 1986), with the market growth being mainly attribuiable to the acccierating
commercialization of pharmaceuticals. Medical equipment is in Japan a fast-growintindustry which comprises close to 20 imporant makers. Three leading companies IToshiba, Hitachi and Shimadzu. Medical informatics develops rapidly, e-speciaity tocat
area networks for hospitals and medicat IC card systems.
On the research side, Japan's Science and Technology Agency will begin in 1988 a studyto carry out exploratory work to fund a project to develop advanced cquipment fordecoding DNA. Sequencing the whole genome with a totaily. automated, rapid DNA
sequencing system, would take 30 yean instead of 250 years and ECU l.l billion if doneby hand. MITI has proposed in 1986 the Human Frontier Programme with the intention
to promote basic research on a world scale which includes medical and bio-informatics.
EUREKA Projects
- Galeno 2000: Development of non-invasive medical measuring methods
- Expert System for incorporation in medical instrumens
- Biomedicat Image Processing
- Ultrasonic Signal Capture Systems
- Oncology Therapy Advisor
- Protein Design
- Operating room 2000
- Medical disposable sensors
- Automated diagnosis of blood
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COST Actions
Cost 13 : Artificiat Intelligence and Pattern Recognition.
Among the collaborative research projects is 'Artificial Intelligence in Medical Science".
Ttre objective is to study and critically evaluate:
- communication between the clinical staff and a decision support system;
- knowledge acquisition by apprenticeship, literature and learning from example;
- knowledge representation techniqucs for medical datq
- handling of uncertain medical dat4
- decision support systems with clinically acccptable response times.
Community
Research and development co-ordination programme of the EEC in the field of medical
and health research:
Three coordination prog,rammes of medical and health research have been adopted by
the Council between 1978 and 1986. A fourth coordination programme encompassing
more than 70 concerted actions is expected to become operational until 1989. Ref.: COM
(86) 549 finaliE.ttope against cancer' programme: proposal for a plan of action 1987-1989. Ref-: COM
(86) 717 final
The Community has specific programmes both on information technology and
biotechnology. itre ESPRIT and RACE programmes address the information and
telecommunication technologies respectively. The Biotechnology Action Programme
(BAp) does include some aspects of the applications of information technology. AIM is
conceirred as a well focused specific effort to complement these programmes with respect
to developing specific advanced and new capabilities.
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6. GLOSSARY
AIM
Ambulatory care
Angiography
Angioplasty
APACHE
Architecture
Artificial Intelligence (AI)
Automatic encoding
AVG's
Bio-Informatics
Biomolecular modelling
Biosensor
Biotechnology
Advenccd Informrticr in Mcdicinc
crrc rcndcrrd rithout holpitrtiration - ic primery crrc, outprticntr horpitrt
cena, cmcrgcnclr vititt rnd onc-dty cerc .urgcqf
Tcchniqucr for dcpicting blood vcuclr
I[rryr ofdcaling rith obetrclcr to thc flow ofblood - cg by lrrcr
Acutc Phyriology rnd Chronic Hcdth Evduttion, I ctrsificetion ryrtcm
dcvctopcd et thc Gcorgc Wuhington Univcnity Intcnrivc Crrc Rcrcrch
Unit
Thc rclcction, dcrign, rnd intarconncction of thc phyrical componcntr of i
largc rcelc computcr ryrtcm
Thc conccpt thrt computcn cen bc progrrmms\il to grumc romc caprbiliticr
normrlly thought to bc lilc human intclligcncc, ruch g lcerrring, rdaptation,
and rclf-corrcction. Applicationr rlro Lnorn er lntclligcnt Knortcdgc Bucd
Syrtcmr (IKBS)
Tnnrformrtion of cach mcdical tcrm in natural tangragc into r codc ineidc
thc computcr, rithout human intcrvcntion
Ambulatory virit Groupe. Methodology uecd in thc unitcd statcr to dcfine
thc product of hcelth crn in embulatory rctting
Thc vrriour topice rt thc intcrfacc bctrccn inforzrrtion tcchnology and
biotcchnologr. onc important ettributc ir that bio-informaticr covcrr not
oDly thc pracnt u.r of computcn for inforrration proccering in
biotechnologr, but aleo thc potcntieh for computcriration within thfu arca
A rcicntific field at thc intcrfacc bctwccn edvanccd computing ud
biotechnology. Main arear inctudc drtabarer of nuclcic acid rtructurcr,
protcin rcqucncc!, macromolccular cryatel rtructurcr and organic cryetet
3tructurcs' rlqu.ncc modclling for laboratory rcqucnca and cloning etudieg
and for dctection of eequcncc homologicr bctsccn diffcrent molecules,
prcdiction of protcin ltructurc from amino acid rcqucncc to model both
eccondary and tertiary rtructure, macromolecutar Gncrgy calculetiona, and
molccular graphicr to dirplay and manipulete reprcecntationr on cailigraphic
and rartcr tcrecn!
A device which recognisca an analytc in an appropriate eamplc and convcrtg
itr concentration into an clectricel rignal via a ruitabtc combination of a
biological rccognition ryttem end en clcctrochcmical trantduccr
Application of rcicntific and engineering principlcr to thc procceting of
matcrialc by biologicel ag€ntr to providc gooda end rcrviccr
Bus
CART
ccD
CIM
Classification
Coding
coM(86) s49
coM(86) 717
COMAC.BME
Computer graphics
Compatibility
Computer language
cosr
CREST
Data Integrity
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An intcrconncctcd rlntcm prth ovcr which inforrnrtion ir trenrfcrrcd, tmm
rny onc of mury rounsrr to ury onr of m"rny dcrtinrtionr, thc dcviccr
involvod bcing connrctcd in prnllcl
Thc Noritic Rrdiqrephic plrnnin3 projcct invotvia3 indurtry, R.tzD
inrtitutt lnd urcrr for thc dcvclopmcnt of ncr rtdiqnphic ryrtcmr rnd
com,municrtionr
Cbargc-Couplcd Dcvicc. I ncr end comprct imrgc rcmor tcchnology
Computcr Intcantcd Mrnufrcturing
A dirtribution by clrrcr or crtcgorio, follorin3 pcrxirtiq critcrie. Thc
Intcta$iond Clurifrcrtion of Diresor (tCD) hrr boca dcrigncd for
rtrtirticd purpdc. urd for 3hc indcxing of horpiSd rrcordr by dircucl rnd
opcntionr, for drtr rtorrgc rnd rctricvrl
Thc codinS of dirclo or mcdicrl tcrmr ir 3hc procar of *tributing r codc
3o c*h notion which ir to bc rcpu*cly idcntifiod, Thir notion can thcn bc
found in r clurificrtioa or r nomcnclrturc
Proporrl for r rcrclrch rnd dcvclopmont co-ordinrtion progrrmmc in thc
6cld ofmcdicrl rnd hcrlth rocerch (f9E7-f9Eg)
Propord for r plm of rction qrinrt crnccr (te87-tsa9)
Conccrtcd Action Comrnittcc-Biomcdicel Enginccring
Thc urc of computcrr to proccu 3nphicr. Unlitc imrgc pr.occting, thc
irnegcr rrc not from lifc but tF. man- or mechinc-mrdc. Gnphicr trc cericr
to menipuhtc thrn funegcr bocrurc thcy rrc dclincd to r computcr'l 'mind"
u 3comctric fi3uru - r rct of pointr rnd a fcs othcr bitr of information
rcguding rheding or coloring
Rcfcn gcncrdly to thc rbility of two (hardwa,n/roftwrrc) dcviccr to rorl in
conjunction
A rct of charactcn, convcntionr, rnd rulcr tbat ir urcd for convcying
information
Committcc of Europcrn Coopcration in thc ticld of Scicncc ud Tcchnology
Thc Scicntific rnd Tcchnical Rcrcerch Committcc. Sct up in 1971, it ir
comporcd of rcnior otfrcirlr of thc mcmbcr ttrt.. and givcr edvicc to both
thc Commirion and thc Council
Datr murt bc rcccivcd u rcnt urd not bc chrngcrblc by a fdrc euthor or by
'noirc' in thc ryrtcm, rt rny point cn muto or rt cithcr rcndcr or rcccivcrtl
rtation without bcing dctcctrblc by thc lcndcr or rcccivcr
Proccdurc rccording rhich thc dete uc rccn within r modcl thrt dcfince
thcir rcletionrhipr end mcening in ordcr to mcct informetion rcquircmcntr.
Detr modclr cxtrectcd from information nccdr form thc buclinc from which
to rpproech thc qucrtion ofinformrtion tcchnology ryrtcrnr
Data modelling
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DSA
ECG Ehctrocudiqnphy
ECOuOmleS Of lntegratlon Ecoaoric rdvratr3cr rriri4 fton multiplc urc urd thcrdorc Usbrr utility
of frcllitir
Economlcs of scele A&rntr3q rririnj out ol rcde of production or rctwicc
EcOnomles Of scope Advrntrg:r rririnS out of com,monrtity rnd ryn r3y bctrccn difcrsrt
productr or rrwicl
Electronlc Imtge Proccsslng Thr ur of drctronic irnqin3 technoloSr ia 3he crptun, rton3:, procrrria3,
onliac ntricvrl, tnarnirion ud dirphy of bioncdicd documratr rnd
medicd tmq*y
ElectrOphOreSiS Scpurtion of nrcrornotrculcr rccording 3o thrir rire rod doctricd chrrgc by
prrin3 tbrou3h r 3cl under thc inlluenco of rn deetric 6dd
Endoscopy Tbc urc of Ocxible tubcr for in vivo erminrtion, dirlnoeir md trcetmnt
ESPRIT Europcrn Stntcaic Prqnurmc for Raoucb rnd Dcvctopmcat in
laformrtion Trchnolqy
ESWL Extncorporrrl Sboct Wrvr Litbotdp.y, rn rpprntur which pcrmitr thr
frqrrrntetioa of litbirra (rtono) in urolo6r, by tnnrfcrdnj rcctur thc
3bruo tonrdr thl litbiur rhocl srva produccd outridc tbe body
Indurtrid cooperrtion rbrnp in hi3b tcchnolo3y commcrcid dcvclopncnt
A computcr ploar.nr thrt rimuleter or mimicr thc judgcmcnt end rreroning
of hurnrn oxpcrtr, rllorin3 it to rddrcu problcmr norrnrlly thought to
rcquirc humrn rpecidbtr for thcir rolution
A long, flcxiblc cndolcopc uring opticel fibrct 3o trenrmit thc imegcFibroscope
Functional specificstiotl Dcfraition of whrt r dcvicc/ryrtcm ir dcrisncd to do but not hor it ir donc
DNA
DRG's
Eureke
Expert System
Genome
Harmonisatlon
Dcorcyribonucldcrcid
Dir3ncir Rrlltd Groupr. DBG'r ur r rubcluriGcrtioa of 3be ICD-9-CM
codo tbrt jr,oupr prtirotr by diqnotic c*tjoriel dtb homo3eacout Go.t
bued on lca;lb of rtry rnd nrrdicd rctivity udyrir
D[itd Subtrrction Andotnphy (roc dro rn3iofrrphy]
All humu 3cncl ttcn togcthcr. Morl thea 3.5 billion chcmicel unitr mskc
up the humur SGnorncr rnd only l%3o2% ofthc acnomc her becn rqucnccd
An incrrirc in conrirtrncy of rpprouha rrthcr thrn r rtrict confomrity of
rncrrurrrncnt ryrtrmr. Hrrnpaintion crn rbo bc obtrincd through r
lcrrnin3 prcca.r by r trrnrpurncy of rcrultr md morrr ryrtcmttic
intcrartionrl cxchrngc of conrprrrblc inforrnrtionr
A drte rocording tochniquc rimilrr to rn opticel dirl but in r crrd formLaser Crrd
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Llthotrlptor Apprrrtur rhich rtlorr lhr fn3nrntrtion of lithiur ia ur,otogr.
E:<tncorporrel rhocl rrvr litbotripy (Eswt) rlton frrgrnrntrtion of rtltonc' by trrnrfor rcrur 3hc Siruer torrrdr tbr lithirrb of r mecbuicrl
rrvc $ucrd outride thr body
' Man-Mechine Intcrfecc tnter*tion of thr urr ri3h r computc or corannuaicrtion rptrn
MBDS Tbc Mialmurr Brie Drtr Set, rrcomnrcndrd by thc EEC t! l9t2
MBI Mcdicd- rad Bio-tnforsrrticr
MEDIA A Fnnch uocir'tioa 3roupiq fivc pilot ternr ia medicrt Infomrtlcr
Medicrl Rccord lnfonrrtion rcguirrd in tbr proccr of medicd couuttrtioa, rxrmiartion,
lnvati3rtion, rnd trrrtrmat
Medicere A US. jweranent projrrmm of nredicrl crr,r erprcidly for the r3od
MIB Tbr mcdicrt lnfonanti'on bul, r drndrrd conrnualcrtionr pr,otocot for
inrtrurnentrtioo ut d i! borpitdr, rad prrticutrrly for iatrarivr cln
MITI The Jr,prnoe Miairtry of tndutry rnd Forl[u Trrde
Molecular Biotechnology A nrerrch feld rhich plryr r lcy ro6 tor hedtb c.r\r, Gj in 3hc form of
diqnodic totr, dru3r, hormoncl, protcinr, vrcciner end to on
MRI Mryactic Rcronrncc Imqin3
NHS thc IIK Nrtionrl Hcrlth Scrvicc
NM Nuclcrr Medicine
OSI Open ryrtrrar iat4rrtion rtrodudr
PACS Pictur.r Archivin3 rnd Communicrtion Syrtcm
PET poritron Emigion Tornognphy
Portability Thc ability of e,n rpplic*ion 3o bc phyricrlly movcd rith .rr. or urcd on r
. vrricty ofdilfcrcnt typcr ofcomputcr
PPS Thc Prorpcctivc Prymcnt Syrtcm of thc U.S. Mcdicrrc pFogtrmrDc
Pre-competitive R&D Mid- to long-tcm R&D pnccecding comrncnciat product dcvclopmcnt
Pre-normative R&D RtrD rcquircd 3o prcprr.c thc dcfinition of rtrnderdirrtion propcrtr
Primary Health Care Eocntirt hcetth crrc mrdc uaivcrrrlty rccaribte to lndividudr rnd frmilig
ia 3hc comrnunity by mcenr rcccptrblc to thcm, throu3h thcir ful
puticiprtion tad rt r colt thtt thc comrnunity end couatry crn rlford
Procedures ln health carc
RACE
R&I)
Secondery Care
Snart card
SMEs
SPECT
Standardisetion
Telemedicine
Tertiary care
Voice processing
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Medicrt tnrtnrnt rnd in prrticulrr ruryicd intcwcntionr follow rpccific
rulcr of conduct involvinS thc prticnt, hfihly tnincd rpccidirtr rad rpccirl
fecilitisr in r hotpitd rcttinS (c6. crrdi* crthctcrintion, hpuorcopy, livcr
biopry, cndorcopy rith biopy)
R&D in Advrnccd Communicrtionr Tochnologicr in Europc
RclcElch rnd Dcvctoprncnt
crrc providcd (r) in I clinic or ofiicc locrtcd et I hotpitd, by r conrultrnt
rpecielirt, (b) in rcutc or 3cncrel horpitrb
onc portrbtc rtorrSc rnd procc[in3 devicc urcd for rutbcaticrtion, prymcnt
rnd rtorr3c of pcnond datr. Smrll rnicroproccoor or mrmor:r chipe rrc
cnceprulrtod in I plrrtic crrd mcctinS ISO rtrndardr. With cxirtinS
tcchnologicr up to 6l Kbitr crn bc rt prr*nt bc rtorcd'
Small- ead Mcdium-rircd cntcrprircl
Singlc Photon Emilion Gomputcr TomoSnphy
str,ndardiretion of mcdicrl drtr ir intcrartiond hrrmonintion of mcdical
tcrrninoloSicr r|itb ctudficrtionr r,nd oomcnclrturcl rlloring to rncodc
rrlcdicEl tctut
Thc urc of tclcmrticr to oficr mcdicrl rcrviccr
long-tcrm cr'rc p,tovidcd throqb lon3-dry io rpccial hocpitlb, nurring
homcr, rnd rimilar rcridcntiel feciliticr
Voicc procoring tcchnolo3y Sivcr r comPutcr thc rbility to bcer and rpcal'
Thcrc crpabiliticr rrc providcd by two dirtinct rtPcctr of thc tcchnology:
voicc rccognition, rhich ttlotr e computcr to undcrrtmd rpolcn rordr rnd
.xccutc thc epproprirtc commrndr or rctionrl lnd voicc output, which
cndowr thc computcr rith rpccch
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Proposal for a Council Regulation on a Community action in the field of informarion
technology and telecommunications applied to health care 
- 
Advanced informatics in
medicine in Europe (AIM) 
- 
Pilot phase
COM(87) 352 final
(Submitted by tbe Commissiott to the Council on 1.3 August 1987)
(87 /C 3ss/02l'
THE COUNCIL OF THE EUROPEAN COMMUNITIES.
Having regard to rhe Treaty establishing rhe European
Economic Community, and in parricular Article
l30Q (2) thereof,
Having regard to rhe proposal from the Commission,
Having regard ro rhe opinion of the Economic and
Social Committee,
In cooperation wirh the European Parliament,
rJilhereas the Community has as irs task, by establishing
a common market and progressively approximating
the economic policies of Member Srates, to promote
throughout the Community a harmonious development
of economic acrivity and closer relarions between the
States belonging to it;
Whereas rhe Heads of State and Government emphasi-
zed the importance of health care as a maior factor for
economic growth and social development;
r00hereas the European Parliament, in its assessment of
the situation and developmenr, srressed the role of
cooperation in health care and related areas for the
future political, social and economic development of
the Community;
Whererr the European Parliament, in its assessment of
biotechnology in Europe, has stressed the importance
of medical biotechnology and bioinformarics (t);
u7hereas the Economic and Social Committee supporrs
initiatives in this domain:
rWheleas, with the emergence of advanced and rnobile
communication services and the progressive introduc-
tion of computing in health care and services, the con-
ditions for major improvements for health care and
possibilities for reduction of cosr increases are
emergffi
\07hereas developments in health care will benefit the
general public and the internarional competitiveness of
the European industry and health services in particular;
(l oJ N" c ? 6,23. 3. 1987, p. 25.
Whereas advances in health care will contribute to
resolving pressing social needs associated with changing
age structures;
\Uhereas the concerted efforts in this domain will con-
tribute to the creation of the internal market and pre-
vent the formation of new internal fronriers to health
care;
tUUhereas the development of common functional speci-
fications for equipment and services will permit the
less-developed regions to benefit fully from the efforts
of Member States piloting the improvements of health
care, management and infrastructure developments in
the Community;
\ilhereas the development of the health care infrastruc-
ture technology and services offers a wide range of
opportunities for small and medium-sized companies
in the manufacture of equipment and in the provision
of specialized services within the Community;
!flhereas cooperation in pre-normative and pre-com-
petitive research and development towards the develop-
ment of standards can make a major contribution,
notably by facilitating the evolution towards future
more effective health care also at regional and local
levels;
Whereas the framework programme for Community
actions in respect of research and tecirnological develop-
ment (1987 to l99l) (2) envisages the utilization of the
technologies of information, telecommunications and
broadcasting in the interests of new services of common
interest under its second heading 'Towards a large
market and a society based on information and com-
munication'; whereas the framework programme con-
tains special provision for a Community action in the
field of medical and bio-informatics;
Whereas the constitution or consolidation of a specifi-
cally European industrial potential in the technologies
concerned is an urgent necessity; whereas its benefici-
aries must be industry, health care service providers,
research establishments, undertakings, including small
and medium-sized enterprises and other bodies estab-
lished in the Community which are best suited to attain
these objectives;
(2) coM(86) 430 final. ?a
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r07hereas exploratory investigations have confirmed the
1...d-."14 the advantages of eommunity cooperation in
this field:
lWhereas it is in the Community's interest to consolidate
the scientific and financial basis of European research
by means of the involvement to 
" 
gr."t., extent of
participants from European third countries in certain
Community programmes and particularly in pro-
grammes involving cooperation in medical bio-infor-
matics;
lWhereas the AIM pilot phase'will benefit from the
results of ESPRIT and RACE as well as the on-going
efforts in standardization:
lWhereas the Community's programme in biotech-
nology_(1985 to 1989) will iniluJe the application of
medical bio-informatics and draw on the iisults of the
work to be undertaken under AIM:
IJfhereas there exists a need for close coordination
with actions on the narional level and periodic reviews;
whereas it is therefore necessary for ihe execution of
the pilot phase that the Commission be assisted by a
Committee;
'Whereas the implementation of concerted actions in the
COST framework is an essenrial element ro comp-
lement industrially-oriented research and development
prolects;
Whereas the Scientific and Technical Research Com-
mittee (Crest) has expressed its opinion,
HAS ADOPTED THIS REGULATION:
Article 1
1. A pilot phase of a Community acion in the field
of medical and bio-informarics, hereinafter referred to
as 'AIM', is adopted for an inirial period of 18 months
commencing 1 January 1988.
2. The action is designed, in concertation with public
and private actions in the field of medical and bio-
informatics (MBI) undertaken at national and inter-
national level, to promote the competitiveness of the
Community's indusrries, health service providers in
order to make available to the citizens and health
services, at minimum cost and with minimum delav.
the improvements in health care, thereby contributing
to social as well as economic obiectives.
Article 2
The action shall consist of rhe developmenr of a com-
mon conceptual framework for cooperation, pre-nor-
mative work and technology exploration and the inves-
tigation of the non-technological factors as required for
the objective of concerting European efforts in improv-
ing health care by means of MBI.
The scope of the AIM pilot phase is described in the
Annex and in the draft workplan.
Article 3
1. The detailed objectives of the action to be under-
taken are defined in a work plan ro be adopted under
the procedures set out in Article 7.
2. The evaluation of projects is carried out by the
Commission having regard to the objectives defined in
the Annex and in the work plan. The eligibility of
projects involving a research and development effort
exceeding 50 man-years is to be decided under the
procedure set out in Article 7. For other projects the
results of the evaluation will be brought ro the norice
of the Committee referred to in Article 5.
3. Projects relating ro the action shall be execured
by means of shared cost contracrs to be concluded
by the Commission with industrial enterprises, service
providers, universities, research institutes and other
organizations established in the Community. Contrac-
tors shall be expected to bear a substantial proporrion
of the costs, which should normally be at leasr 50o/o of
the total expenditure.
4. The proposals for projects shall, as a general
rule, be submitted in reply to an invitation to tender
published in the Official Journal of the European Com-
munities and involve the participation of at least two
independent partners, not all established in the same
Member State. One of the partners shall be a commer-
cial undertaking.
5. In exceptional cases, where the call for tenders
has not resulted in a satisfactory response, in case of
urgency or in cases where the call for tenders is nor
the right procedure in point of cost-effectiveness, the
decision may be taken, in accordance with the pro-
cedure set out in Article 7, to derogate from the prin-
ciples set out in paragraphs 3 and 4.
Article 4
Where Framework Agreemenrs for scientific and techni-
cal cooperation between non-Community European
countries and the European Community have been con-
cluded, organizations and enterprises established in
these countries may become partners to a project under-
taken within this action.
Article 5
1. The funds estimated as necessary for the Com-
munity contribution to the execution of the pilot phase
5r
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amount to 20 million ECU over 18 months, including
expenditure on staff (nine A, two B and four C tempor-
ary officials).
2. The indicative allocation of these funds is set out
in the Annex.
Article 5
1. The Commission shall ensure that the action is
oroperly performed and shall take the measures necess-
".y'to ihir end, without preludice to 
the procedures
provided for in Article 3.
2. The Commission shall be assisted in the execution
of its tasks by a Committee' composed of two represen-
tatives from each Member State, chaired by a represen-
tative of the Commission and hereinafter referred to as
'the Committee'.
The members of the Committee can call on the assist-
ance of experts or advisors according to the nature of
the problems under study.
The proceedings of the Committee shall be confidential.
The Committee shall adopt its own internal procedures.
The Commission shall provide the secretariat of the
Committee.
3. The Commission may consult the Committee on
any matter within the field of application of this Regu-
lation.
Article 7
'\il7here the procedure laid down in this Article is to be
followed, the chairman shall refer to the Committee a
draft of the measures to be adopted. The Committee
shall deliver its opinion on this draft within a time limit
set by the chairman in relation to the urgency- of the
matter. This shall normally be one month and in no
case shall be longer than two months. The opinion is
delivered by the maiority specified in Article M8 (2) of,
the Treaty'for decisions which the Council is required
to adopt on a proposal from the Commission. In the
Committee the votes of the representatives of the Mem-
ber States are weighted as indicated in that Article. The
chairman does not vote.
The Commission shall adopt the measures under con-
sideration when they are in accordance with the opinion
of the Committee. When the measures under consider-
ation are not in accordance with the opinion of the
Committee, or in the absence of an opinio:r, the Com-
mission shall submit to the Council without delay a
proposal relating to the measures to be taken. The
Council shall decide by a qualified majorit".
If, after the expiry of a period of one monr h following
the Council's ionsiderafion of the matter, the Council
has not taken a decision, the proposed m(asures shall
be adopted by the Commission.
Article I
The result of the action shall be reviewed lry the Com-
mission after 12 months. The Commission shall report
to the Council and the European Parliarrent on the
results of this review, together with any proposals for
modification or prolongation of the actior which the
Commission deems appropriate.
Article 9
1. t$(lith regard to the coordination activities pr-o-
vided for in Article I (2), the Member St ttes and the
Commission shall exchange all appropriate information
to which they have access and which the;' are free to
disclose concerning activities in the areas covered by
this Regulation, whether or not planned o:'carried out
under their authority.
2. lnformation shall be exchanged according to a
procedure to be defined by the Commissi<,n after con-
sulting the Committee, and shall be treated as confiden-
tial at the supplier's request.
{
{This Regulation shall
1988.
Article 10
enter into force or 1 January
This Regulation shall be binding in its :ntirety and
directly applicable in all Member States.
3r
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ANNEX
INTRODUCTION
The rationale developed in the main document illustrates the opportunities for cooperation but also the
difficulties and complexities their inter-sectoral nature will pose to a concerted effort on a European scale.
Besides the need to refine obiectives one will need to analyze alternative approaches as well as test the ability
to manage successfully the numerous inter-dependencies. Success of this action will ultimately depend on the
ability to complement and reinforce efforts undertaken by the sector actors on a national level. Developing
and reinforcing the mechanisms of concertation between the sector actors on a European scale is as much a
challenge as the technical content of this initiative. Success in this respect will be decisive for realizing the
advantages of concertation and cooperation and thereby a better use of the scarce human, institutional,
technical and financial assets of the Community in this domain'
For this reason a pilot phase has been conceived with the sector actors which has the following aims:
- 
analyze and assess future requirements in health care and biotechnology for medical and bio-informatics
(MBI),
- 
explore and assess technological developments and options with respect to their contribution to progress
in MBI.
- 
define precise objectives and the optimal approach for concertation and collaboration in the field of MBI
at European level complementing and re-enforcing efforts of private and public organizations working in
this and closely related areas,
- 
test and validate the organization and management support for concerted efforts in MBI'
- 
develop an action plan for MBI based on analyses of future requirements and opportunities,
- 
identify legal, regulatory, economic and other non-technological factors which may play a key role in
using MBI for the stated obiectives.
The following section describes the scope of the work proposed for the pilot phase. The areas of investigation
and explorati,on have been chosen in accordance with the above obiectives of the pilot phase so as to provide
significant results without preiudice to the follow-up.
1. DEVELOPMENT OF A COMMON CONCEPTUAL
FRAMEWORK FOR COOPERATION
Health care is in a process of continuous evolution and so is the
technology supporting it. Central to the assessment of the role
and contribution of MBI is the accurate understanding of the
present and future role of information and the way it is used.
The types of data a doctor generally needs to handle, review,
merge ln a report, are:
- 
text (e.g. reports from colleagues in the referral system),
- 
numeric laboratory results,
- 
graphical presentations (of both numeric data and body sites),
- 
signals (e.g. electro-cardiograms),
- 
images (e.g. X-ray, sonograms, etc.).
These data have three main origins: data they generate themselves
about patients, data others generate about their patients, and
general medical knowledge.
The data handling requirements of researchers working on the
molecular basis of biological systems are:
- 
automatic collection of experimental data from different
sources,
- 
comparison of experimental data with those stored in data
banks and data bases,
- 
tertiary structure prediction from sequence data,
* molecular modelling,
- 
quantum mechanical calculations for structure refinement.
This suggests three directions for the development of medical
informatics:
a) medical records;
b) communications; and
c) information retrieval/decision-support systems.
Formulating a strategy about information technology for health
care requires to identify the information needs and how they
can best be met. This implies the analysis, understanding and
agreement between the main actors concerned as to the approach
best suited to meet user needs in a way which is consistent with
economic and technological constraints.
r3
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1.1. Development of a reference model for MBI
Objectiue
The developments in MBI will build wherever possible on the
developments in information technology, telecommunications,
broadcasting and value-added services. In addition, and relating
to the application specific aspects MBI will develop specific
features and capabilities. For example, remote patient monitoring
may feed into cellular radio, but will require the development of
data capture and broadcasting techniques specific to health care.
Similarly protein and nucleic acid data bases will use standard
data base management systems, but will need special tools, e.g.
expert systems, to assist in the efficient use of the data.
To permit MBI to build on synergy with other domains and to
help identify the requirements in common functional specifi-
cations and minimum standardization, it is proposed to srarr, as
part of the pilot phase, with the conception and development of
a reference model for MBI. As far as the telecommunications and
broadcasting is concerned, this work can build on the reference
model developed as part of the RACE programme.
The specific obiectives of this work are:
- 
to create and maintain transparency for the requirements and
their functional characteristics.
- 
to come to a common understanding of the evolution in MBI,
- 
between the main sector actors to come to a common defi-
nition and understanding of the functional and minimum
standardization requiremenrs,
- 
to support the work of common functional specifications and
of standardization by the appropriate bodies to facilitate
progress in MBI for health care and research in related
domains.
1.1.3. lntegration and interoperation concepts
This work would concentrate on analyzing and :xtending the
OSI concepts for open interconnection for the fiel:l of MBI. As
far as equipment is concerned, it will build on ()SI work but
extend the concept'open interconnection'to the !ector specific
upper layers of the OSI model. Main issues include rccess control
and user identity; electronic signature and time stamping; con-
fidentialiry; data integrity.
7.2. Data requirements analyses for MBI
Objectiue
In order to develop information systems which rre open and
flexible in meeting the needs of health care by building on
the evolution of the underlying sciences and techrologies, it is
necessary systematically to analyse information requirements.
The understanding of information requirements is rhe pre-requi-
site for the conception and definition of commorr information
processing functions and the development of information
exchange and portability. This in turn is a pre-requisite for
common functional specifications and minimum standardization.
Scope
The scope of the work needs to include the anal"ses of health
care related information requirements and the speci iication of the
associated specific features relating to data capture, processing,
verification, protection, authentication, storage, transmission,
recall, and presentation for the following relationslrips:
- 
patient-health care services,
- 
doctor-patient (correspondence, information, alvice, etc.),
- 
doctor-reference informatiorf (case history, diagnosis of
symptoms, prognosis, treatments options, prescriptions,
recent experiences in treatments, etc.),
- 
doctor-diagnostic services (laboratories),
- 
doctor-therapy (surgery, dispensaries, special therapies of
various kinds),
- 
doctor-administrations (hospital, insurance, pt blic adminis-
trations, accounting, etc.).
With respect to the laboratories and research infr,rstructure for
health carc, the corresponding analyses will need to be carried
out including the following relationships:
- 
scientist/technologist-reference information (e,g. DNA and
protein sequence and structure data bases, literirture, etc.),
- 
scientist/technologist-experimental data (e.g. X-ray and neu-
tron diffraction); two-dimensional high-resolrrtion nuclear
magnetic resonance, electron microscopy),
- 
scientist/technologist-experimental equipment (r:.g. molecular
dynamics simulation, X-ray crystallography, : dvanced 3-D
graphic system, etc.),
- 
scientist/technologist-administrations (hospitak or other ser-
vicedemander, insurance, public administration;, accounting,
etc.).
The result should identify the options and the approach for the
development of application-specific coding structures, allowing
for technology expansion and refinement for data transmission
Jcope
The work will comprise three major elements, namely those
relating to the informatics environment of the doctor, the
scientist/technologist working in related domains, and the general
requirements for the development of the reference model.
l.l.l. Reference model for the doctor information enuironment
This will include all the functional descriptions relaring to the
information processes involving the doctor in his relationship to
the patient and the supporting infrastructures (e.g. hospitals, etc.)
and services (e.g. laboratories, etc.). In identifying and describing
the functional requirements both technical as well as cosr con-
siderations will be taken inro account.
1.1.2. Reference model for tbe scientist/tecbnologist infortnation
enutronment
This covers the functional description relating to the work of
scientists and technologists working in health care related
domains, e.g. laboratories engaged in diagnostics, but more gener-
ally those engaged in biotechnology. Though the scope of biotech-
nology goes beyond health care, rhe bio-informatics requirements
are to a large extent common to all domains of biotechnology.
1&f
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in processable form. Within the scope of the pilot phase this
could already be expected to make a significant contribution to
the urgently needed harmonization of future developmenrs as
well as prepare the ground for furrher detailed work.
1.3. Assessment of the cost-performance potential of MBI
Objectiue
Informatics can be used in health care and biomedical research
both to increase performance and to achieve better economres.
The objective of rhis work in the context of the reference model
is to investigate rhe cost-performance porential of MBI.
Scope
The work in this domain will consist of the identification of
the various levels of the health care sysrem where information
technology provides opportunities to develop merhods for con-
taining costs yet improving care. Specifically the following areas
will be scrupulously investigated:
- 
prescribing,
- 
radiology-image processing,
- 
laboratory equipment,
- 
benefit of sensor techniques,
- 
population screening,
- 
cancer therapy,
- 
primary care,
- 
biomolecular research.
Prescribing
With the development of expert system- and communications-
based approaches to primary care prescribing the administrative
overheads can be reduced and the accuracy of matching parient
needs improved.
Radiology
The use ofdigital techniques and optical disk storage, by generat-
ing a much more advantageous data acquisition, storage and
retrieval system, can significantly reduce the annual cosr of radi-
ology today in comparison with X-ray film, chemicals, currenr
equipment maintenance and film storage (1).
Laboratory equipment
IJfhile the cost of maintenance of laboratory equipment, com-
puters excluded, is considerable, adoption of a policy of having
expert system diagnostics in even the most simple laboratory
equipment would permit economies and improvement in servlce.
Sensor techniques
Advanced sensorics offer considerable potential for remote and
(l p*.tur" of X-ray films accounts for 2o/o of theoverall budget
of a hospital and 60o/o of its radiology department.
unattended sensing. This can be used to greatly improve monitor-
ing, accuracy and overcome time and distance constraints,
Population screening
Information technology can improve population screening for a
curable but otherwise fatal disease, by enabling much of the
preliminary detailed screening to be automatic.
Cancer therapy
The quality of life of a cancer patienr can be significantly
improved by the use of computer rnodels aid decision-making
allowing for better trearmenr, e.g. optimizing rhe use of surgery,
chemotherapy and radiotherapy. The challenge is to link the
information base with the developing models to optimize therapy
for each patient.
Primary care
A combination of new measurement technology and information
processing enables better primary care to be provided, showing
how technology convergence operates ro rhe advanrage of healrh
care. In particular, development of 'alternate-sire' medicine
requires convergence of film technology, chemistry, molecular
biology and information processing.
Bio-molecular research
Bio-molecular research has the potential of revolutionizing the
economics of pharmaceutical production and the related research
and development. There are already examples where bio-molecu-
lar engineering techniques have been able ro produce directly
highly pure substances at greatly better economics than rra-
ditional techniques permitted.
2. MEDICAL INFORMATICS ENVIRONMENT
Description
In context of the rapid development of technology and automared
information systems, standards are required to enable compari-
sons and exchange of health information at international level.
Medical data availability and comparability in Europe should
allow better understanding of the patterns of evolution of chronic
diseases, optimize resources with the resulr rhat the quality of
care and the quality of life will improve and contribute to
management and research to the benefit of patients.
The growth of information technology in medicine is now leading
to a proliferation of independenr sysrems in Europe. Thus, there
is a danger of an increasing lack of comparability between medical
information systems that will limit the possibility of large-scale,
national or international studies, as well as the possibility of
evaluating the efficiency and qualiry of care at the European
level.
The first priority is therefore to produce the required commonalty
of medical languages as the fundamental basis for transferable
systems through design and development of a European medical
lexicon of syntax and semantics. This lexicon will form a focus
for most of the medical functions, thus allowing for rhe develop-
ment of the concepts of integration and convergence in health
care.
?r-
,ll
Official Journal of the European Communities 31. 12.87No C 355/16
Objectiue
The main oblective of the work under this heading is.to achieve
the development of improved classification systems for the coding
of mcdicaI terminology as a prerequisite for the solution of trans-
boborder health care problems.
At a scientific level, the adoption of comparable classification
systems is particularly important to obtain a better understanding
of the differences in the spread of diseases as well as of differences
in health care delivery systems and their cost in Europe.
At a political level, accurate and reliable data bases are vital for
the monitoring of the efficiency and the quality of care' as
well as for the development of strategies and of international
standards.
Scope
To meet this obiective, four major areas of activity are required:
- 
international comparison of diagnostic criteria and pro-
cedures related to costs (hospital in-patients),
- 
definition of a minimum basic data set (MBDS) for ambulat-
ory care in Europe,
- 
semi-automatic encoding of standardized medical data classi-
fication systems in Europe,
- 
development of European criteria to define severity of cases.
2.1. International comparison of diagnoses and procedures
related to costs
Obiectiues
- 
Harmonization of medical data classification systems through
comparisons and cornmon results, using the European MBDS
defined for hospitals.
- 
Evaluation of the diagnosis related group (DRG) method-
ology in Europe, to understand differences and explore ways
of comparisons.
This work has an exceptional importance in order to coordinate
actions generated independently in each European country in the
field of MBDS and diagnosis related groups, and to understand
better differences in health services activities, productivity and
quality of hospital care in Europe.
Scope
The work in this part will consist of seven strongly interrelated
areas:
Development of standards for data input
The two maior aspects of this work concern the definition of
standards for the collection and interpretation of medical data,
taking into account that manual procedures are more and more
being replaced by computerized data entry and processing.
Differences in diagnostic classification systems
among European hospitals
!0henever MBDS are available and comparable within and
between countries, pilot studies will be designed to obtain data
exchange and comparisons in Europe, and betweerr Europe and
the United States.
Differences in classification of procedures
among European hospitals
Unlike diagnoses, which tend to be uniformly classif ed according
to the international classification of diseases, operations and
other procedures are coded by national class.fications or
nomenclatures which have been elaborated follou ing different
requirements of clinicians, health care managers, fin, rncing bodies
and social insurance funds, for various purposes, mainly adminis'
trative in nature. The task is to upgrade any classific rtion systems
of medical data in order to cope with evolutiorr of medical
techniques, new diagnoses and management change;, taking into
account that the original classification schemes of procedures in
each country might include some better organizations than the
ICD-9-CM code. The study of a combination of a minimum set
of medical data from each European classificatior scheme will
eventually be developed internationally.
Differences in case-mix among Europt an hospi-
tals
As a first step it is recommended to carry out a c,rmparison of
the international classification systems measuring the costs for
specific case-mixes for European hospitals, e.g. IOD-9, ICD-9-
CM and DRG's, and to develop an approach to harmonizing
their use.
Inf luence of case-mix on length of stay and cost
factors in European hospitals
As resources tend to be allocated according to past :equirements'
new indicators are needed to measure the productivity of health
care delivery systems. The most widely available sc urce of medi-
cal indicators of productivity indicating why cerrain care has
been delivered to patients appears to be the medical record
summary that includes the hospital MBDS with all ,liagnoses and
procedures performed for each in-patient. The ryork will be
aimed at obtaining a better description of the healtl. care delivery
systems in Europe by linking MBDS levels, abr'tracted from
medical record summaries with financial data as rvell as know-
ledge data bases.
De f inition of proposals to harmoniz e medical
data classification systems in Europ,:an hospi-
tals
Programs will be developed in Europe to harmonizt medical data
classification systems. They must be as universi I as possible
- 
taking into account needs of all countries, including under-
developed countries 
- 
and flexible in order to allo w for changes
in the future. The approach will be multi-disciplinrry, to enable
dialogue between health professionals and manage's.
Definition of research and developmertt require-
ments in software and hardware to all )w compe-
titiveness with the US industry
Harmonization of medical data is a prerequisite fo: a large-scale
European market in medical informatics. In order to have the
capacity to compete against strong American c<,mpanies, the
European industry will be supported to design and frrrther provide
well adapted packages that include MBDS and DRG's.
3b
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2.2. Definition of a minimum basic data set for ambulatorv care
in Europe
Obiectiues
- 
Harmonization of medical data classification systems by
defining a MBDS for ambulatory care, e.g. the core of knowl-
edge that should be available everywhere in a comparable
way for the maximum number of usages in ambulatory care.
- 
Evaluation of the ambulatory visit groups (AVG) method-
ology in Europe to explore its feasibility, advantages and
disadvantages.
Scope
The scope includes the following tasks:
Definition of an MBDS for ambulatory care
So far in Europe only a small number of general practitioners
(between 1 and 5 % in different countries) use computers to
process medical information. Standardization of classifications is
therefore a prime concern. The task is aimed at the validation of
standardization concepts and pre-normative work for the coding
in ambulatory care and the definition of a MBDS for family and
out-patient care.
Use of the MBDS defined and of the AVG method-
ology in pilot centers in Europe
Once a MBDS has been defined at European level, there is a
strong need for assessing the ambulatory visit groups method-
ology which has been developed in the USA in 1985, in order to
compare medical data linked with financial data in ambulatory
care.
Definition of proposals to Iarmonize medical
data and patient classification systems for
ambulatory care in Europe
The definition of a MBDS in ambulatory care which is of para-
mount importance in the frame of health care delivery systems
will allow the requisite preparations for the harmonization of
medical data classification systems.
Def inition of research and development require-
ments in software and hardware to allow compe-
titiveness with the US and Japan
Building on the advanced professional know-how in ambulatory
care in Europe and the considerable experience in the field of
financial data on ambulatory care, the work will define software
and hardware specifications for medical data classification sys-
tems in ambulatory care.
2.3. Semi-automatic encoding of standardized medical data
classification systems in Europe
Objectiues
- 
Encoding and decoding from natural medical language to
international classification systems.
- 
Automatic grouping of these classifications into sub-classifi-
cations related to costs (DRG's for in-patients and AVG's for
our-patienrs).
- 
Harmonization of rules for medical data classification svs-
tems in Europe.
This work has a strategic importance for the development of
coherent health indicators and thereby health services standards,
as well as the development of harmonized medical information
systems that could generate a large industrial market for medicine
in Europe.
Scope
Specifically the work
activity:
Development of
pean languages
is to concentrate on two maior areas of
standards for diagnoses in Euro-
This work aims at meeting the need for standards in extensions
of the ICD-9 coding scheme for diagnoses in Europe. Semi-
automatic programs for encoding medical diagnoses will be
designed and then made available on a European scale. Coding
could be part of an expert system front-end which, apart from
coding transparently from free-text input will incorporate con-
text-specific coding and automatic error detection and correc-
nons.
Development of standards for procedures in
each European language
Comparisons will be made between national procedures for cod-
ing schemes and between extensions of international classifi-
cations and nomenclatures that are currently being generated
in several European countries. The appropriateness of those
classification schemes will be examined in relation to their use
for different purposes: epidemiology, cost control, severity of
cases, quality of care, clinical research and management at all
levels. Application specific coding structures will be investigated,
allowing for terminology expansion and refinement for data
transmission in processable form.
These procedures must be compatible with DRG's and AVG's,
which requires the development of editing programs and grouping
programs.
2.4. Development ofEuropean criteria to define severity ofcases
Obiectiue
The objective of this part is to obtain a simple set of criteria to
determine the severity of cases in hospital and in ambulatory
care, allowing the better assessment of the productivity of health
services in all European countries. Work in this domain will
provide a better understanding of the cause of health care costs,
a better control of costs adjusted to the need of the population,
and a large potential for the market of hospital information
services and ambulatory care systems.
The strategic importance of this work is summarized hereunder:
- 
variations in costs have been shown in the USA as well as in
some European studies to be largely dependent on the severity
of cases, but criteria to define 'severity' are not yet standardized,
even in the USA,
- 
criteria of severity should, be easily available countrywide.
They can be based either on an analysis of the content of the
ji
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MBDS or on physiological signs (like the Apache system in
intensive care).
Scope
Physiological indicators
The task is to select physiological indicators in relation to inten-
sity of care and severity of cases, with linkage to financial data.
Complications and procedures in DRG's
The work in this domain is aimed at refining the definition of
DRG's in relation to intensity of care and severity of cases, with
linkage to financial data.
3. DATA STRUCTURES AND MEDICAL RECORDS
Description
As information requirements are identified, the data to meet
those requirements must be carefully defined if they are to be
consistent, aggregated, manipulated for a variety of purposes,
exchanged and shared. As the data will be processed and stored
in computers of different types at different locations, they must
be seen within a model which defines their structure. This is a
prerequisite for the computerization of medical records. Regard-
ing the broad medical market with abundant varieties of initiat-
ives in hardware and software developments mostly without
conceptual links to each other, only major breakthroughs in the
conceptualization and development of the medical record can
dramatically enhance the quality of medical care and at the same
time really open the market as the doctor is the major actor in
the field and provides the main market target. The potential
growth of the demand is therefore very strong, but first requires
standardization and harmonization work to be achieved at Euro-
pean level.
Obiectiue
The objective of this part is to stimulate work at a European
level in the development of medical data and process models as
a key to progress with information technology in health care,
and to foster concertation on the common functional specifi-
cations and minimum standardization required for the computer-
ization of medical records and progress in portable storage tech-
nrques.
Scope
To meet these obiectives, this part would comprise three major
areas of activity:
- 
clinical data and process modelling, the development of which
is essential not only for information transfer across bound-
aries, but also as dynamic reference models for voice input,
image processing and so on,
- 
specification of the functional requirements for a general
distributed medical record,
- 
common functional specifications and harmonization pro-
posals for patient data cards to be used for storage of a single
patient's relevant data.
3.1. Clinical data and process modelling
Description
The lack of transferable understanding of a set of facts is often
a serious impediment to the solution of day-to-day problems and
to long-term progress. This is particularly true in medicine,
pharmacy, therapeutics, and biotechnology, where there is a data
set which needs to be understood by a non-specialist in that
particular data. Clinical data modelling needs to re developed
for ensuring transferability of data and processes. In principle,
the clinical process (a patient's entry to' passage :hrough, and
exit from clinical care) can be expressed as a serres of related
data and process statements. These can be formally encoded to
provide a scheme describing the care of the patient. Since the
scheme is based on the patient and the disease, the:e is minimal
dependence on style of practice.
Obiectiue
The obiective is to design standard clinical data mod,:ls acceptable
across Europe. This will enable the reference model to operate
in any required direction at any required level of care.
Scope
Specifically the vork is to concentrate on:
Development of a common coding s< t
The task is to develop a common coding sei integrating the
requirements of medicine and data protection. Medical codes are
necessary as they provide a satisfactory compressed base for truly
transportable systems, independent of the user lanl uage and the
host system; they satisfy an increasing need to prod.rce statistical
analyses of reliable demographic data on an international scale;
they are required to provide common links for medical expert
systems; data protection can be built into codes in fulfillment of
national obligations, yet the embedded code is still rransportable
between different systems and different users.
Development of common data formats
Common formats are required to represent diseas:s and thera-
peutic processes. They optimize transfer of data and process
information which thereby become independent :f communi-
cations and of host systems. Transferred data can immediately
be reconstructed, whether it is read from an input communt-
cations line, a magnetic tape or a smart card.
Correctness, validation and verifica:ion
At present there are no formal rules of medical c<,rrectness for
validating medical expert systems. One of the grear applications
for expert systems in medicine is their role in definin 3 'normality',
thereby saving staff appreciable time and effort rvhich can be
more efficiently directed to solving the problems of abnormality.
Correctness of medical expert systems is therefore :entral to the
development of biomedical informatics, especially as prac-
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titioners thereby know that a particular system for clinical use
has been formally validared as correct.
3.2. General distributed medical record
Obiectiue
The.obiective is to design a record system thar should provide
easy, flexible structuring and summarizing of complex parienr
records and be integrated with the decision support functions.
The record system must both aid in the care of individual patienrs
and support studies of popularions for research and 'anticiparory
care'. Above all, doctors must find that its usefulness reDays the
effort of entering data and the mainraining system.
Scope
Conceptual studies will be undertaken ro clarify the potenrial
of a harmonized approach to a medical distributed data base/
transaction model. Maior inrerest will be focussed on the
approach of distributed transacrion processing.
Identification of common functional require-
ments
Main activities will be directed to clarifying the requirements
for developing model hospital information systems and model
regional systems using the new rechniques of disrributed trans-
action processing based on medical standards of dara exchange.
Development of standardizarion proposals
Standardization developed in this context may finally lead to
data exchange protocols on the medical application layer conform
to the OSI concepts.
3.3. Medical record system/data cards
Description
As the central source of information for all forms of clinical
practice, the medical record is a key issue in the compurerization
of medicine. The choices made in the design of computerized
medical record systems, which determine not only how medicine
can be practiced, but also how changes can be made in practice
or in computerized activities, are vasr and affect many aspects of
medical communications. There are several issues relevanr ro an
efficient medical record sysrem. The ability to develop systems
on a European basis requires answers to the following questions:
what should be stored in a record? How should information be
stored? Where should data be stored? What medium should it be
stored on?
Objectiue
There are several issues relevant to an efficient medical record
system. Any strategy in information technology for health care
will depend on projects incorporating studies on the design and
use of medical records. In this section reference is made ro patient
data cards to be used for storage of a single parient's relevant
data. The conceptualization and harmonization of this developing
technology has to be thoroughly prepared in order to develop
standards efficiently.
Scope
Specifically the work in the following areas is envisaged:
Card technologies
The task is to stimulate collaboration and concertation in the
analysis of the requirements and opportunities in card rechnol-
ogies, e.g. improved storage capacity for smarr cards, mixed
smart-optical cards, readers, writer-readers.
Pointers
Adequate addressing is required for use of pointers which, stored
on the card, would allow retrieval of certain information, such
as X-ray pictures, if necessary.
Archival storage
New techniques for adequate archival storage have to be investi-
gated.
Picture storage
Compression techniques for picture storage require further devel-
opments.
Medical records storage
The task is to define methods for storing medical records in a
hierarchical fashion, from a brief description of episodes, infor-
mation used to reach a diagnosis, and related data.
4. COMMUNICATION
GRATION
AND FUNCTIONAL INTE-
Description
Medical informatics still relies to a large degree on isolated
solutions implying costly and wasteful procedures of transferring
information between the different processes occurring in the
health care system. Establishing communications between rhe
range of equipment and systems in use and under development
offers considerable saving in terms of cost, but even more import-
antly in terms of time and flexibility. Beyond establishing the
ability to transfer and access information there is the potential
of removing some of the inherent redundancy in stand-alone
equipment and facilities. This is referred to as 'economies of
integration' and means simply that as a result of functional
integration resources can be shared between equipment and fa-
cilities giving a considerable improvement in cost-performance
and flexibility.
However, the benefits of 'economies of integration' require the
realization of functional integration and inter-operability going
beyond the simple exchange of information.
Objectiue
The work in this part is to invesrigate requirements and tech-
nology options in the domain of medical communications by
jq
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concentrating on some specific aspects of particular importance
for future developments.
Scope
The scope includes the consideration of the information flow and
communication functions specific to the health care system. The
proposed work is structured in distinct work areas described
below.
4.1. Hospital information services
Description
The functioning of a hospital is highly information-intensive and
has very stringent requirements. The information needs to be
available when and where needed often with no advance notice
or even real-time; the system needs to function in a reliable
manner; the services it offers must be well adapted to both
the medical personnel and, in parts, to the patients, placing
considerable demands on the human factor engineering of such
systems in order to make them user-friendly.
These and other requirements specific to the hospital environment
make hospital information services an issue requiring special
attention.
Local area network techniques as developed for office automation
will provide the basis for the development of information services
in hospitals, but additional efforts will be required to meet the
specific needs of health care.
Hospital information services require an interactive computer
based system which will progressively integrate and automate the
entire flow of information in a hospital. Although there are still
discussions about the choice between \ierarchical and relational
data bases for information systems in hospitals, the trend is
towards integration of patients' information at the data level.
Hospital information services in the 1990s will be provided from
a central data base where diagnoses and procedures will be part
of the long term patient abstract. The data base will be analyzed
through a query language and accessed through a central com-
munication system. The collection of data will be done from
peripheral units or personal computers at admission and dis-
charge points. Encoding will be facilitated by a data dictionary,
a knowledge base editor, a data interpreter and a knowledge
base.
Objectiue
As there should be no formation of internal frontiers to health
care it is of great importance to start the reflection on the
requirements and functional specifications of hospital infor-
mation services early enough to permit a coherent development
in this sector facilitating the collaboration between hospitals, of
hospitals with insurance and administrations, and also to make
the hospital administrative procedures easier and more trans-
parent to patlents.
Harmonizing present efforts and at the same time preparing
actions for the future require focussing on the definition of a
hospital information network. lJUithin this initiative the objective
would be to obtain a close collaboration of European industry
and health care experts in the investigation, conception, designing
and development. A maior advantage of such a development
would lie in the further foundation of a European-'vide standard
in medical local area networks which could be used in connection
with other efforts in harmonization to develop an attractive
market and to contain health care costs.
Scope
Further developments in technology, notably in the areas of
communications, local area networks, distributed ; rocessing and
data-base systems/techniques as well as in the Protiress made on
the agreement to international technical commu:rication stan-
dards, mean that the present emphasis in the art:a of hospital
information services is on the integration of the <Lifferent func-
tional systems within a hospital into one unifierl inftrrmation
planning and management system.
The scope consists therefore in bringing togethe' the relevant
European companies, the health care specialists an I health econ-
omists to develop the basic design and prerequisites for a common
standard in hospital information networks.
Specifically, this work will have to include the con;istent investi-
gation of all the main aspects of integral informati,rn processing,
i.e. medical standards for data exchange, medical bus, intercon-
nection to medical instrumentation, and so on'
The medical information bus
The task is to define a standard communication; protocol for
instrumentation used in hospitals, particularly for tntensive care.
A wide range of instruments used in hospitals la:k a common
means for data acquisition, and often lack comput:r-addressable
interfaces. Furthermore the development of closerl-loop control
for drug infusion or ventilation has accentuated rhe need for a
simple means of computer control. The medical information bus
is explicitly designed to meet these deficiencies an< needs.
Picture archiving and communicati<,n systems(PACS)
The object in developing PACS is to assist the tar ks of storage,
archiving and transmission of images in diagnostic radiology
departments. Ultimately techniques developed fo' thrs purpose
may also be extended for other medical communicrttion purposes
and even for other functions. The specific task her: is to support
the work carried out by Etrropean actors in the identification of
the common functional requirements of PACS.
4.2. Wide area biomedical information services
DescriPtion
'Within modern health systems there is a growing need for wide
area communication services. This is due to sever tl reasons, the
ma jor ones being the promotion of primary health ,:are (including
home care), the propagation of real-time informa:ion regarding
transplants, drug security, nutrition, environmettt, etc. Other
aspects of health care also require wide area setvices, e.g. the
linking of laboratories in quality assurance progra nmes' etc.
Typical user requirements of wide area biomedic'rl information
services include the provisions of general clinical da ra, the transfer
4o
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of laboratory analytical data. This implies the exchange of data
files of several megabytes concerning structural analyses or digiti-
zed images.
In the related research areas there is a need for unrestricted access
to the large data-bases and collections which form the basis for
modern biotechnology. Among these are:
- 
nucleic acid and protein sequences,
- 
structural data on proteins and biopolymeres,
- 
genetic maps,
- 
vectors for nucleic acid sequencing.
A start has been made under the BAP which provides for
improved access for researchers to nucleic acid and protein
sequence data-bases, to a monoclonal antibody data bank and to
strain collections. However, this access needs to be extended to
encompass structural data, genetic mapping libraries, cloning
vectors and bibliographic data-bases, etc. and to take in industry
as well as academia.
AIM is in this context to develop new tools to address these
objectives.
Obiectiue
The obiective is to offer a universal solution to the need for a
common biomedical network which takes account of such aspects
as time zone differences and holiday periods in Member States,
and also the need to deal with functional aspects such as unread
messages.
Scope
It can be expected that most wide-area communication needs for
health care applications will be met by the general development
of telecommunication services, i,e. requiring no specific actions
to be taken. However, the use of these techniques for health care
may raise a number of operational, regulatory and political issues
which need to be identified in time and for which appropriate
answers need to be found. These may well impact the technical
and operational features to be developed. For these reasons this
limited analytical work is included as part of the pilot phase.
The scope will include preparative work on electronically- or
optically-linked terminals, and on link by a portable riredium
such as a compact disk.
4.3. Data protection/authentication/fail safe
Description
In the context of health care some of the most sensitive data-
protection issues arise. Data protection is a fundamental aspect
of data handling which will gain in importance as health care
networks grow, as information networks grow, as the community
becomes more litigation conscious, and as information gains in
commercial value in response to the world-wide competitive
position of Member States. As a consequence, consideration of
data protection becomes enmeshed with details of international
standards, network developments, computer architectures and
the means by which data transferable systems will work indepen-
dently of system and network architectures. The issue is complex,
for data protection has to be very high for the individual, yet the
mechanism of data protection has to be sufficiently transparent,
so that it does not impede the legitimate and authorized use of
the data.
Objectiue
Positive identification of authorized users of data is an important
issue which needs to follow the organization and management
of health care. Fail-safe considerations are also application
specific. The standards developed, e.g. for office automation, are
not necessarily adequate for health care. The objective of this
work is therefore the identification of the functional and technical
requirements as derived from the needs in health care.
Scope
The scope of the work will include all generic information
handling operations in health care and the supporting services.
It is to include the concerns of the individual, whether as patient,
doctor, researcher, economist or legal specialist.
4,3.1, Asse ssment of the data plote ction, authentication and fail-
safe requirements in MBI
Objectiue
\0?ith the participation of the main actors concerned with the
development and use of MBI systems, the issues of data protec-
tion, authentication and fail-safe requirements are to be investi-
gated for the health care applications. This will be done based
on a critical assessment of the state-of-the-art with respect to the
requirements. The result will be to identify measures and actions
to provide adequate solutions.
Scope
Data-protection aspects involve all areas of data acquisition,
transmission, filing, interpretation. The scope involves therefore
several aspects such as, e.g., in-house systems, regional systems,
data cards, etc. It also includes related aspects such as data
interpreting.
4.3.2. Deuelopment of international medical data-plotection
protocols
Obiectiue
The obiective is to specify the requirements for protection-based
information handling tools in order to ensure user confidence in
high-efficiency information handling systems.
Scope
The scope of the work is to:
- 
develop a coherent set of good practice rules from which
data-protection principles can easily be adopted as part of
the national legislation for medical information handling,
- 
meet the need to link data protection in computer networks
and individual host machines to systems of patient-portable
data such as data cards,
- 
devise data-protection rules for development of intelligent-
knowledge based systems, building on the satisfactory map-
t*t
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ping of certain questions concerning the data and process
aspects of disease into open systems interconnection proto-
cols,
- 
foster further research on design of large scale data-protected
networks. These aspects include encryption, addressing, auth-
entication of sender, authentication of recipient, notification
of dispatch, notification of arrival, freedom from error, indel-
ible audit of information trails.
- 
define the most effective algorithms for solving the abovemen-
tioned issues,
- 
contribute to the further development of existing open sys-
tems protocols in order to satisfy the medical data-protection
requirement.
5, BIOMEDICAL EXPERT SUPPORT SYSTEMS
Description
Expert support systems 
- 
the marriage between computers and
management science 
- 
are a promising developrnent as expert
systems and decision support systems are merging to create the
software support required for a new type of computer system.
Decision support systems were developed within the data-pro-
cessing world because of the practical limitations of dara pro-
cessing for helping people solve complex problems in actual
organizations such as hospitals or national health organizarions.
Expert system technology reflects a largely independent evolution
that took place in computer science research laboratories in
answer to the limits of traditional computer science techniques
for solving the complex problems that people can solve. These
two separate progressions can now be united to help solve a
broad range of important practical problems.
Obiectiue
The objective of this part is to explore rhe opporruniries of expert
support systems in the field of health care and ro identify the
common functional specifications prerequisite for the emergence
and development of a competitive European market for this very
promising area.
Scope
To meet the objective stated above, this part would comprise the
following tasks:
5.1. Biomedical expert and knowledge-based systems
Description
'Whatever the speed and success of expert systems developments
in medicine, the already observable impact in standard products
of medical informatics reaching from dedicated systems to full
size hospital information systems are remarkable and could even
be more important in a broader sens of quality assurance in
medical care, The same holds for the impact on biomedical
training.
Expert systems can improve the quality of medic:Ll actions by
increasing the accuracy of diagnoses and more specil ic and indivi-
dualized recommendations for medical treatment.
Expert systems can also contribute to control cost cf care:
- 
mistakes are reduced thus allowing for a more e ficient prob-
lem handling,
- 
the diagnostic process can be shortened or logisticalll simpli-
fied (in the sense that less referral from instituti rns to others
is required),
- 
patient-oriented expert systems will enable n ore patients
with chronic diseases to navigate their disease elfectively.
Objectiue
The obiective of the work here is to identify requrrements and
opportunities for expert and knowledge based too s in medical
care and related research domains.
Scope
The task is to investigate and demonstrate rhe :easibility of
European cooperation in the development of artificia I intelligence
tools for health care and related research. In order to limit the
scope it is suggested that the task be restricted initially to a
specific medical problem are^, e.g. diabetes. On-go ng collabor-
ations could form the basis for such an initiative. This experiment
would help to develop the empirical background rn which to
iudge future.work towards sharing of diagnostic tools and other
health care features. Specifically it would be exper ted to show
the impact that these developments could have on quality and
cost containment in health care. Main tasks would include:
- 
definition of a framework for expert systems in medicine,
- 
analysis of knowledge representation,
- 
analysis of medical reasoning,
- 
analysis of the interfaces,
- 
interaction between expert systems and other :ypes of sys-
tems.
The framework for expert sysrems in medicine
The areas of medicine and health care in which it is possible to
apply expert systems are to be identified and the I,ossible con-
ditions for their effective use are to be analyzed.
K n o w led ge re p rese n t a ti o n
The types of knowledge used in health care are to be analyzed
and the way in which the usual techniques of artificia I intelligence
can exhaustively capture that knowledge is to be studied.
Medical reasoning
The various types of expert sysrems usable in healt)r care (diag-
nosis, description of possible scenarios, planning with their
Ltb
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respective architectures are to be analyzed, focussing attention
on the procedural aspects and those that are supposed to be
meta-knowledge.
Interfaces
Starting from an analysis of the existing interfaces used in expert
systems, the characteristics that the interfaces for the next gener-
ation of expert systems should have are to be studied, focussing
attention on both natural language and graphics.
Interaction
The types of systems already existing in an information system
(decision support systems, mathematical models and statistical
package) that will have to interact with expert systems will be
analyzed as well as the type of interaction. Data bases, especially
those that have a universal relation interface. will be also con-
sidered.
,5.2. Dedicated computer language tools
Description
It is proposed to investigate the feasibility of a 'macro language
for health care', i.e. a language building on general purpose
languages but having special features facilitating their use in
health care and related research.
Objectiue
Usefulness, developmental speed and acceptance of applications
on medical communication systems would be greatly increased
if a computer language existed that would support applied
nomenclatures and classification schemes as well as their further
development: meta-information as a tool of integration. The
objective of the work is to explore the options for a computer
language that could support the design and usage of application
software in terms of medical and health organization meta-
data and their contextual (semantic) and syntactical relations
(semantic data models).
Scope
This work could build on the work in ESPRIT and on progress
made in other countries relating to this objective. The pilot phase
could help clarify the chances of success and the timeliness of
such an initiative. The work could also include some exploration
of semantic data models for medical data-base developments.
5.3. Special information processing requirements
Description
Health care and related research very often require the processing
of images or other problems entailing extremely high computrng
power. Although there are a number of European ventures in
novel processors or super-computers, further research and devel-
opment is needed before they can find an application to the
problems in health care and the related research areas particularly
biotechnology.
Real-time high-speed processing of medical information is
required in several areas including:
- 
image processing(1),
- 
voice processing,
- 
real-time and greater-than-real-time modelling,
- 
development of neuromuscular prostheses,
- 
network management.
Among improvements which real-time high-speed processing
could bring to biotechnological research are:
- 
a substantial increase in the quality of information displays
on the screen,
- 
the spreading up of multiple iterative calculations for the
validation of computer modelling of proteins.
Obiectiue
It is proposed to examine the options and the comparative
advantages of special purpose super-computers for the domain
of health care and biotechnological research (this does not mean
that other application areas may not have similar special purpose
requirements). Specifically this work would investigate concur-
rent high order integration computers for biomedicine.
Scope
The scope would include the design and the requirements for its
development, as well as the assessment of the potential field of
application in MBI and other domains of similar needs.
This work can build on the work carried out in the framework
of ESPRIT and national programmes in this domain as well as
the experience in other countries working in this area.
5.4. Human-computer interface
Description
As information processing systems require data input from medi-
cal and other staff, great weight needs to be given to the develop-
ment of the user interface. In particular, there is a strong need
for a clear demonstration that these systems will be of benefit to
the user who has to input the data.
Objectiue
The definition ofEuropean standards and their feasibility requires
a specific effort which is the objective of the work defined here.
Scope
The general usability requires as much harmonization as possible
in the human interface, regardless of the special medical appli-
cation. It has to be developed to serve under the special working
conditions of doctors taking into account also the requirements
for efficient data orotection.
-
(r) Medical scanning accounts for llo/o of the US image-pro-
cessing market. Fast-developing applications range from
dynamic cardiac imaging to fracture analysis and use of
biosensor-derived informarion.
r
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5.5. Flcxiblc open-architecture infercnce systems
Description
Use of information technology by physicians will largely be
affected by the future developments in artificial intelligence which
will require the ability to offer high-speed graphics and inferential
processing in a form accessible to a large market of practitioners.
In practical terms though, present developments are of limited
usefulness as they neither provide integration with every day
system aspects, as e.g. the patient data-base, nor provide for
interconnections or transferability. To realize its potential useful-
ness, artificial intelligencc has to be part of an integrated concepr,
where it plays the role of the assistant in every day work.
Obiectiue
The oblective of the work in this domain is to design a 'flexible
open-architecture inference system' as well as investigate its
potential with respect to the technical features needed for
efficiency and adaptarion to user needs.
Scope
The scope is aimed at the definition of a high-level operating
system which, using in-built expertise, can speedily and unam-
biguously interface with quite different system functions from
different positions within the system. Specifically the task is to
analyze and assess the requirements for the design of a net of
interacting experts, in which every expert gets the same initial
data and during the consultation process the output of the others.
Further realization may be in a system of local distributed expeits
connected by a local area network or one computer with parallel
processing facilities.
6, BIOMEDICAL INSTRUMENTATION AND RESEARCH
TOOLS
Description
Biomedical instrurnentation is one of the key factors of progress
in MBI and is crucial for its future development. Information
technology embedded in biomedical instrumentation represenrs
the single most important factor in the explosive advance achiev-
ed in biomedical research. The crucial importance of inregrarrng
advances in all technological domains including, in particular
advances in information technology, telecommunications and
broadcasting is expected ro persist for the coming decades.
lVhile European scientists rank high in the international compari-
son, the productiviry of their work is lower, i.e. the time spent
for a given research result is very much higher. In other words
the productivity of European research and development, not the
quality, is lacking compared with other developed regions. This is
to a large extent due to inadequate progress realized in biomedical
instrumentation and the integration of information technology.
The performance of the Community in rhe timely adaptation of
concepts and obiectives to the technological advances will be
decisive for the cost-performance of health care and also for the
internarional competitiveness in offering health-care products,
equipment and services,
6.1. Integrated biomedical laboratory
Objectiue
The obiective is to investigate the options for re alizing maior
improvements in research and development productivity in health
care and related technological work by a concerted effort in
biomedical instrumentation with particular referer ce to the role
of MBL The specific concept to be explored is that of an inte-
grated biomedical laboratory.
The systematic development of the MBI as applied to biomedical
laboratory activities could lead to the realization of integrated
biomedical laboratories bringing a considerable in provement in
the cost-performance, quality, flexibility, reliabilitl and speed of
biomedical research, i.e. have a maior impact or the research
and development productivity in this domain.
Scope
The scope of investigation of an integrated biomedi:al laboratory
should include:
- 
integrated measurement of biomedical variable s in vitro and
their interpretation,
- 
in-vivo sensors for diagnostics and therapy,
- 
image and data interpretation,
- 
computerized scanning,
- 
magnetic resonance imaging (MRl),
- 
endoscopy, particularly video-endoscopy,
- 
picture archiving and communication systems (PACS),
- 
biochemical analyses,
- 
gene mapping,
- 
protein characterization,
- 
cell screening.
The result is to give clear indications as to the comparative
advantages of the concept of integrated biomedical laboratories
compared with other options of advanced approaches to insrru-
mentation. Furthermore this work is to result in :he definition
of implementation concepts and the specification rf rhe related
technological work and indicate the key factors which would
need to be taken into account,
6.2. Biomedical knowledge bases
Description
The complexity and volume of medical and biotechnological
information is considerable and growing at a rapid rate. Tens of
thousands of genes control specific life processes, three billion
units of DNA form the human genome. rJflith currerrt techniques,
sequencing these three billion units could consume 3 000 man-
years. However, automated DNA sequencing machines are under
development which may cur costs of sequencing a gene ro a
fraction of an ECU within the next decade.
Similar progress is being made in the analysis of otlrer biological
materials and in work on the molecular basis of nedicine and
therapy. However, much of this progress depends o,l the effective
management of the information acquired. Here tte design and
development of biomedical knowledge bases is a ce:tral issue.
q.,
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Objectiue
The obiective is to identify and assess alternative approaches to
manage biomedical information systems and avoid overloading.
This requires the rapid storing and sharing of information from
medical, pharmaceutical and genetic research.
Scope
The information system and therefore the related knowledge
bases need to support biotechnological and genetic research as
well as the development of pharmaceutics, medical research and
medical care. The reason for this need derives from the increasing
use of diagnostics and therapy based on the understanding of
genetic and biomolecular processes.
The scope of the work would initially inciude the issues of
effective information acquisition, organization, maintenance,
retrieval, access, for biotechnological, pharmaceutical and medi-
cal uses.
The result of the exploratory work would serve to identify and
assess the options for effective and economic management of
genetic and biomolecular information.
6.3. Automated DNA sequencing
Description
Progress in biotechnology has led to new techniques for diagnosis,
treatment and prevention of disease. Most of these 
- 
from
new vaccines based on recombinant DNA to the creation of
therapeutic proteins for the treatment of cancer or heart disease
- 
depend on rapid and economic sequencing of DNA.
Over the past decade the rate at which DNA can be sequenced
has increased to several thousand nucleotides per day. US and
Japanese teams are developing automated DNA sequencers which
will increase this by several orders and also reduce the cost.
Objectiue
The obiective during the pilot phase would be the examination
of the options for European cooperation in the development of
automated DNA sequencing. The special emphasis would be on
the application of advanced CIM techniques to achieve high
productivity and reliability of the results. This would be pursued
in close collaboration with biological researchers who are already
involved in the BAP programme in improving sequencing tech-
nrques.
Scope
The work is to include the systematic assessment of requirements
and technology options for automated DNA sequencing.
6.4. Automated protein analyzerlsynthesizer
Description
Besides DNA there is a whole range of biomolecules playing a
key role in medicine and biology. The problems of analyzing
structures and synthesizing them in a controlled manner is of
paramount importance for therapy on the molecular level.
Objectiue
The obiective is the development of an approach to automated
protein analysis and its linking to protein synthesis.
Scope
The scope of the exploratory work to be included here extends
to medical, pharmaceutical and biotechnological requirements
for protein analysis and synthesis. The work is to address primar-
ily the potential of MBI and CIM.
7. NON-TECHNOLOGICALFACTORS
The orientation of technological efforts towards meeting socio-
economic needs implies taking into consideration the conrext in
which the technology is to be used. The optimal use of resources
implies furthermore that the organization and management rssues
are equally taken into account. The political nature of high
technology requires that even at the stage of pre-competitive
research and development these aspects are assessed and the
implications brought to the forefront.
This part of the pilot phase is dedicated to analyzing and assessing
some of the non-technical factors embedding this initiative in the
wider contexr of related activities.
7.1. Investigation of the opportunities of closer collaboration
between national actions
There is already a large effort under way within Europe and
excellent work is being done. However, due to the predominantly
national orientation of these activities, there is a significant
amount of redundancy in the work being undertaken and the
possibilities for synergy often remain unexploited.
The investigation pioposed as part of the pilot phase is to develop
measures to assist existing actors in identifying related activities
and establishing collaboration where appropriate. The investi-
gation and consultation will also include the formulation of
recommendations to facilitate the common exploitation of results
and transfer of technology.
7.2. Review of the functional specification, standardization and
certification practices
The problem of coming to agreed functional specifications and
minimum standardization for the use of information technology
and telecommunications in health care and related research is
complicated by the need to combine the efforts of these organiz-
ations focussed on health care and of others oriented towards
information technology and telecommunications. In addressing
the issues of MBI one will wish to build on existing standardiz-
ation bodies. In order to achieve an effective approach and in
view of the national differences and the multitude of organiz-
ations already involved in one way or the other it is proposed to
carry out a survey of standardization, specification and certifi-
cation practices in Europe and internationally. This work is to
result in a recommandation as to the optimal approach to
addressing future requirements in standardization, specification
and certification in Europe.
7.3. Review of the legal and regulatory framework applying to
MBI
The use of information technology and telecommunications for
health care needs to include appropriate regulatory and legal
t"t \:
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measures to assure the protection of patient interests as well as
the commercial interest of service providers and operators.
In order to avoid the formation of new internal frontiers in the
Community there is a need to engage in an effort aiming at the
definition of common rules and conditions for the introductiori
of MBL
As a starting point for so doing it is proposed to analyze the
present regulations and legislations governing the use and intro.
duction of MBL The work is to result in the identification of the
options and measures which could be developed in order to
support a harmonious development of the regulatory envrron-
ment for MBI applications in Europe.
7.4. Economic assessment of the MBI potential for health care
and biomedical research
Besides the qualitative advances MBI offers for health care the
potential of cost-containment is the most important contribution
to be looked for. However, the relationship between the perform-
ance of a technology or a service and the impact on improvements
in cost-performance are not straightforward. They depend on
numerous other factors and conditions which need to be under-
stood and taken into account. It is, therefore, proposed to investi-
gate the economic impact of MBI on health care and on the
supporting services, in particular biomedical research. The result
of this work is expected to provide an underst:Lnding of the
economics of information in health care and indicate the way
MBI can make the best contribution to improverrents in cost-
performance of the overall system.
7.5. Assessment of special skill training requ,rements and
options to meet them
For the exploitation of opportunities created by technological
advance special training plays a key role. Typi< ally the pro-
fessional staff in place have received their education some 10
years back and even at that stage the education:nay not have
been up to date. Of course there is a considerable investment tn
adult education and training, but in areas which are evolving
very rapidly, as in the case in MBI, special efforts wi.l be needed to
overcome the difficulties of technology and knowledge transfer.
The work proposed as part of the pilot phase is tle assessment
of requirements and the development of a scheme for special skill
training directed at familiarizing researchers and practitioners
with the potential of advanced MBI.
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FINANCIAL STATEMENT
1. Budset Headinq 7345
ddvanced fnformatics in ![edicine in Europe (AIM)
- Pilot Phase -
2. Leeal Base: Article 130
3. Descriotion of nroiect
The global objective is to serve the concertation of European efforts towards
susteined inprovement in health care in the Community for the 1990's within economically
accepteble limits by exploiting the potential of Medicel and Bio-informatics.
AIM is an action of which the present proposal is a Pilot Phase, which Seeks to concert the
development, on a European scale, of the Medical- and Bioinformatics (MBI) services,
equipment, systems, tools, standards, functional specifications and conventions for health
care, by building, incrementally, on equipment, systems and services devised for other uses,
and on complementary actions to realize in the shortest possible delay the advantages of
technological progress for improving the quality and cost-performance in medical care and
its supporting services. The Pilot Phase has 3 Lines of Action.
Action line I:
Improvement of the effectiveness of public and private actions
by means of
the development of a common conceptual framework for cooperation at the
planning and management level
Action Line II:
Strengthening Europe's posture in MBI and health care
by means of
cooperation in pre-normative and pre-competitive technology exploration
concentrating selectively on re-inforcing and complementing teh technology base of
MBI and its services
Action Line III:
The creation of an environment favourable to rapid progress in the introduction
and appropriate application of MBI in health care
by nteans of
the development of specific proposals addressing the policy, regulatory, legal,
organizational framework of MBI applications including the training and manpower
related factors.
4. Justification of the oroiect
Health is next to food and shelter one of the basic human needs. Conscious of the high
priority of health care and of the growing possibilities, but also of the cost constraints, the
Community needs to optimize its efforts towards this common objective. Sector actors havejoined the Commission in identifying actions which are suited to make best use of limited
financial, human and technological resources to exploit the technological advances in Medical
and Bio-informatics so as to bring the maximum care to the patient while staying within
reasonable limits of expenditure.
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AIM seeks, therefore, to take advantage of the progress made in information technolol3y,
telecommunications and mobile communications to contribute to qualitative advances in
medical care and improvements in the cost-performance by means of actions suited to
accelerate progress and to establish synergy between different streams of development and
actors.
MBI equipment and services represent also a major future rnarket opportunity lbr
Community industry, but it will require quick and determined steps to increase the efforts in
this direction and to make better use of existing human, industrial and financial resources, so
as to match the increasing commitment to this domain in other parts of the world.
5. Financial imolications for the intervention aonronriations r)
5.0 Imolications for exnenditure (Million ECU)
5.0.0 Total cost over the whole of the expected duration:
From the Budget of the Communities:
From other sectors at the national level:
5.0.1 Multiannualschedule
20.00
t7.75
TOTAL: 37.75
Commitmcnt Approprietionr 1991
rnd later
Total
Contractr
Pcrronncl Cortr
Adminietretivc Coeta
o.EE 13.59- 3.31
o.10 l.r0 0.a9
o.o5 0.31 0.20
17.76
1.69
o.56
1.0
P ayment Appropriationr 1987 l9E9 1991
and latcr
Total
Contractr
Pcrgonncl Costr
Adminirtrative Cogta
0.35 6.09
o.l0 1.10
o.o5 0.31
7.31
0.49
o.2
4.0 t7.76
1.69
0.66
Total 7.5
Thc Proporal for r Councit Regulation conccrning thc Framerorl Programrnc of Community Activitiec in
thc Ficld of Rocerch e,nd Tcchnologicrl Dcvclopmcnt (1987-1991) COM(86) a30 final includcg thc
provirionr for thir action undcr Action Linc IlI.
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5.0.2 Method of calculation
a) Exoenditure bv contract
This expenditure covers the Community's financial contribution to analytical work,pre-normative and pre-competitive R&D as required for identifying functionai
specifications, standardization and technology requirements, carried out normally
under shared-cost contracts (research and development for a total of about 30bMan Years) to be concluded with health care equipment industry, serviceproviders, research establishments, undertakings, including small and medium sized
enterprises and other bodies established in the Community (average Community
financial contribution - about 50% of total cosa).
b) Ooerational exoenditure
Administrative costs (management committee and working party meetings,
consultation of experts, missions, document distribution or dissemination of
techniques, use of data processing, telecommunication and broadcasting equipment).
c) Manaeement staff exoenses
The requirements of this project have been estimated on the basis of a staff of :
t9] temporary officials - category A
t21 temporary officials - category B
141 temporary officials - category C.
This staff is requested under the Budgets E7 to 89.
6. Financial imnlications for staff and current administrative aoorooriations
(See sub-point 5 above - included in the general budget of the Commission)
7. Financins of exnenditure
The appropriations required to cover the Community's contribution to this project are to be
entered in the Community's future budgets.
8. Imnlications for revenue
- Community tax on salaries of officials
- Officials' pension contributions.
9. Tvne of Control
- administrative control by the Director General for Financial Control as regards
budget implementation;
- Scientific Control:
- Management Committee
. scientific control by officials of the Commission
. audit by the Court of Auditors in accordance with provisions of the Treaty.
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IAIM lnd the sME's
AIM is relevant for SltlEs since
- it pro"id"r opfibrtuntties for start ups and other innovetive compenies
high-technology applicetion et e formative stage'
- it reduces the development end innovetion risks by defining common
specificatious, minimum stendards and concepts, thereby reducing
barriers for SMEs, rnd
to enter a
functi rnal
the entry-
- creates opportunities for the dlrect involvement in pre-normative and ,lre-
competitive work on e European scrle.
The object of AIM, as a complement to Medical and Biotechnological Research Programrnes,
is to stimulate and support the development of Medical and Bioinformatics which is a cnrcial
infrastructure for progress both in health care as well as the development and application of
Biotechnology.. Thelupply side is at the moment largely in the hands of a few speciali:t IT
and telecom- equipment manufacturers with the services relying largely on techniques
developed primarily for other uses. However, in order to exploit the potential of MBI the
practitioneis, hospitals and innovative specialized service providers have a major contribtrtion
to make. Within the consistent framework for action in MBI to be created by AIM these
innovative SMEs will tre able to engage with a calculable risk and peFpective.
Part of the development of MBI depends on the creation of a European market-place - ie a
means whereby buyers know where to seek information on what is available and suppliers
can let it be known what they have to offer. The market-place is thoroughly imperfe:t at
the moment, even nationally, and AIM will help to make it function, via communica:ions
links and contacts, at the Community level.
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